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CHAPTER I 
 
INTRODUCTION 
 
Brief history and epidemiology of Helicobacter pylori 
 Prior to 1984, the human stomach was considered a sterile organ. It was thought 
that the low gastric pH would prevent bacteria from growing or persisting in this 
environment (89). Any bacteria found in the stomach were considered to be transient 
and likely to be constituents of saliva or swallowed food. Then in 1984 a group reported 
isolation of a bacterium from the stomachs of patients with gastritis (89). The isolated 
bacterium was eventually named Helicobacter pylori. In 1994, the World Health 
Organization designated H. pylori as a group 1 carcinogen (52). H. pylori colonization 
results in gastric inflammation and is a risk factor for the development of gastric 
adenocarcinoma, gastric lymphoma, and peptic ulcer disease (4, 112).  
 Typically, the host is colonized by H. pylori early in life and colonization persists 
lifelong (5, 21). The actual mode of transmission is presently not understood. H. pylori 
currently colonizes approximately half of the world’s population (5). The actual rate of 
colonization is different for different parts of the world. In Africa, for example, the rate of 
colonization is close to 90%, while this rate is approximately 50% in North America (29). 
It is worth noting that the rate of severe disease outcomes varies by region. While the 
rate of H. pylori colonization in Africa is very high, the age adjusted incidence of gastric 
cancer in Africa is relatively low (2%) (115). Conversely, while the rate of H. pylori 
colonization is approximately 50% in Asia, the age adjusted rate of adverse clinical 
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outcomes is disproportionately higher (10%) (115). There are several notable reasons 
for this discrepancy. One factor is geographic diversity in genetic makeup of the host 
(67). Individuals with alleles associated with greater production of proinflammatory 
cytokines or decreased production of anti-inflammatory cytokines have an increased 
risk of adverse disease outcomes when colonized by H. pylori (23, 108). Environmental 
conditions, such as host diet, may also contribute to adverse clinical outcomes (23). 
Finally, the genetic composition of H. pylori is a major factor (21). 
 H. pylori is a genetically diverse organism (11, 21). Sequence analysis of H. 
pylori strains has identified several genetic elements that are associated with worse 
disease outcomes (11). For example, colonization with strains of H. pylori that contain a 
genetically distinct region of the genome called the cytotoxin associated gene 
pathogenicity island (cag PAI) is highly associated with the development of gastric 
cancer (18, 22, 138). Another feature associated with the development of gastric cancer 
is the presence of genes encoding specific outer membrane proteins (OMPs) such as 
BabA, SabA, HopH, and type 1 HopQ (17, 54, 88, 98). The presence of the gene 
encoding a form of vacuolating cytotoxin called s1m1 VacA is another genetic element 
associated with severe disease outcomes (6).  
 
The surface of Helicobacter pylori 
 H. pylori is a Gram negative curved bacillus. In addition to the cytoplasmic 
membrane present in all bacteria, Gram negative bacteria are surrounded by another 
membrane referred to as the outer membrane. The outer membrane acts as a 
semipermeable barrier that allows nutrients to pass through while keeping out possible 
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harmful elements such as lysozyme and other antimicrobial agents (13). In addition to 
being a barrier, many biologically important molecules and structures are present on the 
outer membrane. These include adhesins, receptors, transporters, flagella, and pili (2, 
14). While the surfaces of several important pathogens have been studied in detail, the 
composition of the bacterial surface of H. pylori is still relatively undefined.  
 Based on sequence analysis of proteins possessing an N-terminal signal 
sequence and a characteristic hydrophobic C-terminal motif, H. pylori encodes at least 
63 OMPs (3) (Table 1). The characteristic C-terminal motif consists of alternating 
stretches of hydrophobic amino acids likely to form transmembrane β-strands predicted 
to assemble a β-barrel (3, 68). The number of predicted omp genes is unexpectedly 
high considering the relative small size of the H. pylori genome (~1600 genes) 
compared to other bacteria such as E. coli (which also is predicted to encode 
approximately 60 OMPs while having a genome of ~4300 genes) (12, 132). E. coli 
expresses many copies of a few OMPs (105 copies of OmpA for example) while H. 
pylori expresses similar copy numbers of many different OMPs (30, 68).  
 Colonization with H. pylori can persist life-long, and expression of H. pylori OMPs 
can change over time (47, 88). Due to presence of a poly T tract preceding the 
transcriptional start site (TSS), the genes encoding many OMPs can undergo 
transcriptional variation (47, 80). Insertions and deletions within the poly T tract 
preceeding the TSS can lead to altered transcription of omp genes. Another way omp 
expression may be altered in H. pylori is by slip-strand misparing within polynuceotide 
repeats within the 5’ coding region of the genes (47). A possible reason why H. pylori is 
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able to evade clearance by the host is this ability to “turn on” and “turn off” expression of 
possible immune targets (88). 
 
OMPs of Helicobacter pylori 
 H. pylori attachment to epithelial cells has been shown to increase gastric 
inflammation and parietal cell loss in vivo (44). More virulent strains of H. pylori produce 
two known OMP adhesins, BabA and SabA. BabA binds host fucosylated Lewis b 
antigens and SabA binds host sialyl-Lewis x antigens (expressed under inflammatory 
conditions) (88, 93). Lewis antigens are carbohydrate structures that are produced by 
epithelial cells. Lewis antigens are assembled onto glycolipids and glycoproteins, and 
are the major determinant of host blood type (142).  
 H. pylori OMPs are classified into several families based on sequence analysis. 
H. pylori OMPs were initially identified by the presence of a semi-conserved carboxy-
terminal domain (approximately 250 amino acids long) and were subsequently classified 
into two families known as Hop and Hop-related. Hop stands for “Helicobacter outer 
membrane porin” based on the observation that HopA, HopB, HopC, and HopD 
functioned as porins (30, 98). This group has 32 members and the semi-conserved 
carboxy-terminal domain is predicted to form a hydrophobic transmembrane β-barrel 
(3). BabA and SabA are characterized as Hop OMPs. Due to the high sequence 
similarity between many OMPs, it is hypothesized that these proteins fold into similar 
structures. HopZ, BabB, SabB, and OipA, are other Hop OMPs associated with worse 
disease outcomes, but unlike BabA and SabA, these OMPs lack a known host binding 
target (98). The distinction between the Hop and the Hop-related OMPs is that Hop 
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proteins encode a conserved signal sequence cleavage motif, while the Hop-related 
OMPs do not (3). In addition to the Hop and Hop-related OMPs, H. pylori is predicted to 
encode Hof (H. pylori outer membrane protein family), Hom (H. pylori outer membrane 
proteins), iron-regulated, and efflux pump OMPs (Table 1) (3). HomB is an example of 
an OMP associated with adverse clinical outcomes in children colonized with H. pylori 
(102, 103). The iron-regulated OMP FecA3 has been described as being essential for 
mouse colonization (9).  
  
6 
 
Table 1. Different families of predicted H. pylori  OMPs (3) 
Family 1: Hop Gene Size 
 
Family 2: Hof Gene Size 
HopZ HP0009* 672 
 
HofA HP0209 450 
HopD HP0025 711 
 
HofB HP1083 479 
HopM HP0227 691 
 
HofC HP0486 528 
HopA HP0229 483 
 
HofD HP0487 480 
HopF HP0252 487 
 
HofE HP0782 455 
HopG HP0253/0254 471 
 
HofF HP0788 499 
HopJ HP0477 367 
 
HofG HP0914 514 
HopH HP0638 305 
 
HofH HP1167 471 
HopE HP0706 273 
    SabB (HopO) HP0722* 644 
 
Family 3: Hom Gene Size 
SabA (HopP) HP0725* 653 
 
HomA HP0710 660 
BabA (HopS) HP1243 733 
 
HomB NA 668** 
HopC HP0912 515 
 
HomC HP0373 700 
HopB HP0913 529 
 
HomD HP1453 746 
HopK HP0923 369 
    
HopI HP1156 396 
 
Family 4: Iron-
regulated Gene Size 
HopL HP1157 1230 
 
FecA-1 HP0686 767 
BabB (HopT) HP0896 708 
 
FecA-2 HP0807 792 
HopQ HP1177 641 
 
FecA-3 HP1400 841 
HopN HP1342 691 
 
FrpB-1 HP0876 791 
HopU HP0317 745 
 
FrpB-2 HP0915/0916 815 
    
FrpB-3 HP1512 879 
Family 1: Hop-
related Gene Size 
    HorA HP0078/0079 684 
 
Family 5: Efflux pump Gene Size 
HorB HP0127 286 
 
HefA HP0605 477 
HorC HP0324 254 
 
HefD HP0971 431 
HorD HP1066 200 
 
HefG HP1327 412 
HorE HP0472 186 
    HorF HP0671 270 
 
Other Gene Size 
HorG HP0796 278 
 
NlpD*** HP0506 403 
HorH HP1107 230 
 
BamA HP0655 916 
HorI HP1113 277 
  
HP0694 257 
HorJ HP1469 248 
  
HP0726 305 
HorK HP1501 388 
  
HP0358 511 
HorL HP1395 242 
  
HP1467 231 
    
FlgH HP0325 237 
    
OmpP1 HP0839 587 
    
PalA HP1125 179 
    
Lpp20 HP1456 175 
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 * Gene is out of frame due to CT repeats at 5’ of gene 
** Gene absent in strain 26695, protein size from strain J99 
*** Annotation determined via NCBI BLAST multidomain  
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Other known H. pylori surface-exposed virulence factors 
 In addition to a diverse repertoire of OMPs, H. pylori produces 2-6 unipolar 
sheathed flagella (Figure 1). The flagellar sheath is a continuation of the outer 
membrane and extends throughout the length of the flagella. HpaA is proposed to be 
one protein component of the flagellar sheath (83). Isogenic mutants defective in 
flagellar function are incapable of colonizing animal models (104). H. pylori uses 
chemotaxis to evade the low pH conditions present in the stomach (24). It is 
hypothesized H. pylori uses chemotaxis to localize itself near the gastric mucosal 
epithelia where the pH is closer to neutral (104). Several known adhesins, and perhaps 
many others, mediate bacterial binding to the surface of the host cells. Additionally, 
strains containing the cag PAI produce filamentous structures predicted to be the 
extracellular portion of a type 4 secretion system (T4SS) (Figure 1) (59). The only 
known effector protein encoded by the cag PAI is CagA. H. pylori translocates CagA 
into host cells in a Cag T4SS-dependent manner after the bacteria make contact with 
host epithelia. CagA induces many different cellular changes upon entry into host cells, 
resulting in various phenotypes such as actin cytoskeletal rearrangement and 
chromosomal instability (48, 100). A gene encoding VacA is present in virtually all 
strains of H. pylori (20). Levels of VacA expression and the form of VacA are variable 
among different strains. VacA is localized and secreted from the surface via a type Va 
secretion (autotransporter) pathway (34) (Figure 1). Proteins secreted by this pathway 
undergo Sec-dependent secretion across the inner membrane and are localized to the 
outer membrane via a carboxy-terminal transporter, or “helper” domain that interacts 
with the Bam complex (49, 53). The amino-terminal passenger domain is hypothesized 
to be threaded through the pore that forms from folding of the transporter domain (49). 
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Many type Va proteins are then cleaved either by a helper protease or autoproteolytic 
event and are either retained on the surface (as with many adhesin proteins) or are 
released into the extracellular space. While VacA is found in the extracellular growth 
supernatant, VacA is also displayed on the surface of H. pylori. (49). A notable feature 
of the surface of H. pylori is the observation that the outer membrane Lipid A 
component of LPS is characterized by low endotoxicity. The LPS O antigen is highly 
variable and contains Lewis antigens which mimic similar antigens found on host cells 
(51, 127). Finally, H. pylori is not known or predicted to produce a capsule or encode S-
layer proteins. 
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Figure 1. Surface structures of H. pylori. A) H. pylori flagella. Transmission electron 
microscopy of H. pylori strain SS1 stained with 1% phosphotungstate. Bar represents 
500 nm (123). B) Cag T4SS extracellular pili. Scanning electron microscopy of H. pylori 
strain 26695 in contact with AGS epithelial cells stained with 10 nm thick gold film. Bar 
represents 500 nm (117). C) Cartoon of VacA on the surface of H. pylori. Ribbon 
diagram of solved VacA p55 domain crystal structure is shown in blue (42).  
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Research significance and specific aims 
Identification of surface-exposed proteins of H. pylori 
 Bacteria must sense and adapt to changes in their environment in order to 
survive. The bacterial surface is the first compartment that interacts with the 
extracellular environment. Additionally, with bacterial pathogens such as H. pylori, the 
surface is where the bacteria make direct contact with the host, and must serve to not 
only adhere to surfaces and protect from the constant onslaught of the host’s immune 
system, but is also a substantial repository of virulence determinants. H. pylori is a 
fastidious bacterium that requires rich, undefined media for growth. Additionally, it is 
fragile and prone to autolysis. This makes biochemical and biophysical investigation of 
different cellular compartments difficult to perform and interpret. Several studies have 
attempted to identify surface-exposed proteins of H. pylori. However, these typically 
used only a single approach and often relied on techniques not suitable for hydrophobic 
membrane proteins (such as OMPs and other transmembrane proteins). As a result, 
little is known about the composition of the surface-exposed subcellular proteome of H. 
pylori. The main goal of this thesis was to expand our knowledge of the surface-
exposed protein repertoire of H. pylori using a combination of multiple classical 
approaches and novel techniques. The knowledge gained established a baseline 
composition of the surface-exposed proteome in order to guide future experiments into 
how the bacterial surface may change under various conditions simulating infection. 
The purpose is to gain an understanding of how H. pylori interacts with its environment, 
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how these bacteria can evade the host’s immune system, and how we can develop 
novel therapeutic targets in order to treat or prevent H. pylori infection. 
 While H. pylori genetic composition (such as the presence of the cag PAI and 
genes encoding certain OMPs) is a major determinant of clinical outcomes, 
environmental conditions are another major determinant. Specifically, a high salt diet is 
associated with adverse clinical outcomes and increased inflammation in vivo (40, 62). 
Based on the observation that a high dietary salt intake results in increased gastric 
inflammation in H. pylori-infected animals, I hypothesized that many H. pylori proteins 
change in abundance when the bacteria are grown under conditions to simulate a high 
salt diet. These may include proteins that act to counter salt-induced osmotic stress, as 
well as proteins that may be contributing to adverse clinical outcomes in the host. 
Large-scale proteomic experiments were used to identify possible salt-responsive 
proteins, especially proteins present in low abundance. CagA has been previously 
reported as being salt-responsive (82). However, this protein is secreted into host cells 
through a T4SS-dependent mechanism and thus is not likely to be a source of bacterial-
host surface-surface interactions. Identification of salt-responsive surface-exposed 
proteins would be a first step in the study of proteins contributing to adverse clinical 
outcomes. 
Investigation of CagT, a putative VirB7 functional analog 
 Another important area of research focuses on the assembly and mechanism of 
action of the cag PAI-encoded T4SS (Cag T4SS). CagT is required for Cag T4SS-
dependent phenotypes. The presence of a 4 amino acid motif called a lipobox within 
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CagT is the basis for CagT being annotated as a putative VirB7 functional analog. Other 
than a lipobox motif, CagT has no sequence similarity to VirB7 proteins found in other 
bacterial species. Within the canonical VirB/D4 T4SS found in Agrobacterium 
tumefaciens, VirB7 is a component of the VirB/D4 T4SS core complex. Based on 
studies of the VirB/D4 T4SS, the Cag T4SS core complex is predicted to be the scaffold 
to which the surface-exposed T4SS pilus is assembled upon contact with host cells. 
Exactly which Cag proteins are present on the surface of H. pylori has yet to be 
determined.  
 VirB7 in Agrobacterium and conjugative T4SSs functions primarily as the outer 
membrane anchor for the T4SS structural core (comprised of VirB7, 9 and 10) (39). In 
addition to the lack of sequence homology to VirB7, CagT is much larger than VirB7 
(280 AA compared to 55 AA). To my knowledge, there are no previous studies that 
investigated potential lipidation of CagT to determine if the VirB7 annotation is 
appropriate. To address this, I have investigated the lipidation status and the 
importance of the lipobox within CagT. Any knowledge gained pertaining to CagT would 
potentially guide us in future investigations of how the Cag T4SS functions to deliver 
CagA into host cells. 
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CHAPTER II 
 
IDENTIFICATION OF SURFACE-EXPOSED PROTEINS OF HELICOBACTER 
PYLORI USING COMPLEMENTARY TECHNIQUES 
 
Introduction 
Interactions between H. pylori and the host are dependent on specialized 
proteins localized on the surface of H. pylori (77).  Many H. pylori-induced alterations in 
host cells are mediated by secreted proteins such as VacA and CagA, which are 
secreted by type V (autotransporter) and type IV secretion systems, respectively (20, 
48).  Others include H. pylori outer membrane protein adhesins that mediate H. pylori 
adherence to gastric epithelial cells (54, 88, 99), and surface-exposed components of 
the cag type IV secretion system (T4SS) have important roles in engaging receptors on 
host cells (58, 73).  Some H. pylori outer membrane proteins (OMPs) can stimulate or 
inhibit inflammatory responses (121), and others can modulate the activity of the cag 
type IV secretion system (10, 56, 57).   
 Several approaches have been used to experimentally identify proteins localized 
on the surface of H. pylori or proteins associated with the H. pylori outer membrane. 
These have included analyses of susceptibility to protease digestion (118), 
immunolabeling (114), accessibility to chemical modification (119), and differential 
detergent solubility (8).  These experimental studies have provided useful insights, but 
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most have been limited by the use of only a single method (thus lacking a means for 
validating results) or the use of methods (such as 2D gel electrophoresis) that are 
suboptimal for detecting membrane proteins that are present in low abundance.   As an 
additional complication, it is difficult to separate H. pylori inner and outer membrane 
proteins using methods optimized for studies of Enterobacteriaceae (26, 30). 
Furthermore, H. pylori is prone to undergo autolysis (110), which can potentially lead to 
artifactual surface-exposure of proteins that have an intracellular localization in intact 
bacteria.   
 
Much of our current knowledge about the outer membrane composition of H. 
pylori has been deduced from analyses of H. pylori genome sequences.  The first 
analysis of an H. pylori genome sequence (from strain 26695) identified a family of 32 
genes that were predicted to encode integral outer membrane proteins (132). These are 
subsequently denoted throughout the manuscript as “annotated OMPs”.  A subsequent 
genomic analysis identified 63 H. pylori genes that were predicted to encode outer 
membrane proteins and classified these proteins into several different families (3). The 
largest family, designated as the “major OMP family” or Hop family, corresponded to the 
genes identified in the earlier genomic analysis and was divided into two subfamilies (21 
Hop and 12 Hop-related or Hor proteins) (3).  Among the 21 Hop proteins, at least five 
are reported to function as adhesins (BabA, SabA, HopZ, AlpA, and AlpB) (54, 88, 99, 
107) and several are reported to have porin-like properties (25). In addition to the Hop 
family of OMPs, several smaller families of putative H. pylori OMPs have been 
designated, such as Hof proteins, Hom proteins, FecA-like and FrpB-like iron-regulated 
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proteins, and efflux pump proteins (3). The subcellular localization of many of the 63 
putative OMPs has not been validated experimentally.  
Most of the in silico efforts to identify H. pylori OMPs have been designed to 
identify OMPs with distinctive C-terminal motifs or β-barrel structures (132). Proteins 
exported to the surface of H. pylori through pathways such as the flagellar or type IV 
secretion systems might not possess these features, and therefore might not be 
successfully identified using these approaches. Thus, although the in silico analyses 
provide a valuable resource for identifying candidate proteins that are likely to be 
localized to the outer membrane, these analyses offer an incomplete view of the 
proteins that are potentially exported to the surface of H. pylori. Experimental studies 
are required in order to gain a more comprehensive understanding of the cell surface 
proteome, and to understand how the production of cell-surface proteins might vary 
under different environmental conditions.  
The goals of the current study were to identify and analyze proteins that are 
localized on the surface of the prototype H. pylori reference strain 26695, to test the 
hypothesis that the cell-surface proteome of H. pylori includes additional proteins 
besides those that have been predicted based on in silico analyses, and to elucidate the 
cell surface topology of surface-exposed proteins. To identify surface-exposed proteins, 
I used multiple complementary biochemical and biophysical methods for protein 
separation, coupled with robust mass spectrometric methods for protein detection.  I 
report here the identification of proteins that meet multiple criteria for surface-exposed 
outer membrane localization. These include numerous proteins previously known or 
predicted to be OMPs, as well as cag pathogenicity island-encoded proteins that are 
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required for activity of the cag type IV secretion system, putative lipoproteins, and 
additional proteins that were not previously considered to be cell-surface components.  I 
show that the majority of Hop and Hom OMPs on the surface of intact bacteria are 
highly susceptible to proteolytic cleavage by an exogenous protease, whereas Hor and 
Hof proteins are relatively resistant. I present evidence that most of the protease-
susceptible OMPs contain a large protease-susceptible extracellular domain exported 
beyond the outer membrane and a protease-resistant domain at the C-terminus with a 
predicted β-barrel structure.  These features suggest that, similar to the secretion of 
VacA passenger domain, the N-terminal domains of protease-susceptible OMPs are 
exported through an autotransporter pathway.  Collectively, these results provide new 
insights into the repertoire of surface-exposed H. pylori proteins that may mediate 
bacteria-host interactions, as well as the cell-surface topology of these proteins.  
 
  
18 
 
Materials and Methods 
Bacterial strains and culture conditions. 
 Strain 26695 was isolated from a gastritis patient and fully sequenced (132). The 
variant of H. pylori strain 26695 used in this study contains an intact cag pathogenicity 
island (cag PAI) and a functional cag T4SS, but does not produce flagella (124).  A 
Δcag PAI mutant strain has been described previously (16).   Bacteria were grown on 
either trypticase soy agar plates supplemented with 5% sheep blood or in sulfite-free 
Brucella broth supplemented with 10% fetal bovine serum (BB-FBS) at 37°C in room air 
containing 5% CO2.  
Generation of rabbit polyclonal antisera. 
 Anti-UreA serum was obtained from Santa Cruz. CagA, Cag3, CagM, CagT and 
CagX, derived from H. pylori 26695, were produced as recombinant proteins in E. coli.   
GST fusion proteins, MBP fusion proteins, and 6-His-tagged proteins were purified 
using gluthathione-, maltose-, or nickel-coated beads, respectively. Rabbits were then 
immunized with the purified proteins.    Anti-CagT serum was adsorbed with boiled 
ΔcagT mutant bacteria prior to use in immunogold EM experiments.  
Immunoblot analysis. 
 Proteins were separated by SDS-PAGE and transferred to nitrocellulose 
membranes. Proteins were detected by incubating the membrane with primary antisera 
(diluted 1:5,000-1:10,000), followed by horseradish peroxidase-conjugated anti-rabbit 
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IgG as the secondary antibody (Santa Cruz). Labeled proteins were detected by 
enhanced chemiluminescence (ECL) methodology and visualized using X-ray film. 
Immunogold transmission electron microscopy. 
 H. pylori was grown on trypticase soy agar plates for 24 hours. Broth cultures 
were inoculated at an initial density of OD600 of approximately 0.05 and grown for 20 
hours. Bacteria were harvested in late log phase, corresponding to an OD600 of 
approximately 0.8, by centrifugation at 3,500 x g for 20 minutes at 4o C. Surface 
proteins were labeled using procedures similar to those described previously (124). 
Briefly, cells were washed once in PBS containing 1 mM CaCl2 and 0.5 mM MgCl2. 
Bacteria were then fixed with 2% paraformaldehyde (Electron Microscopy Sciences) 
and 2.5% glutaraldehyde (Electron Microscopy Sciences) in 50 mM sodium cacodylate 
(Electron Microscopy Sciences) for 30 min at room temperature. Bacteria were then 
pelleted at 5,000 x g for 10 minutes. The fixation was quenched with three washes with 
0.1% glycine in 50 mM sodium cacodylate. Bacteria were then blocked with 0.1% cold 
water fish skin gelatin (Electron Microscopy Sciences) for 1 hour at 4° C. Bacteria were 
labeled with CagT antiserum for 1 hour at 4°C. Bacteria were washed twice with 
blocking buffer. Goat anti-rabbit antibody conjugated to 10 nm gold particles (Electron 
Microscopy Sciences) was applied in blocking buffer for 1 hour at room temperature. 
Samples were washed twice with 50 mM sodium cacodylate. Cells were then placed on 
formvar carbon-coated 300 mesh copper grids (Electron Microscopy Sciences) and 
negatively stained with 0.1% ammonium molybdate (Electron Microscopy Sciences). 
Samples were imaged with a FEI T-12 transmission electron microscope.  
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Biotinylation of surface-exposed H. pylori proteins using an amine-reactive biotinylation 
reagent. 
 H. pylori was grown on trypticase soy agar plates for 24 hours. Broth cultures 
were inoculated at an initial density of OD600 of approximately 0.05 and grown for 20 
hours. Bacteria were harvested in late log phase, corresponding to an OD600 of 
approximately 0.8, by centrifugation at 3,500 x g for 20 minutes at 4o C. Surface 
proteins were labeled using procedures similar to those in a previous publication (119), 
with several modifications. These included culturing the bacteria in broth instead of 
plates, use of magnetic beads coated with monomeric avidin (Bioclone, BcMag beads) 
for purification instead of avidin-agarose, and trichloroacetic acid (TCA) precipitation 
instead of acetone precipitation.  Briefly, the bacterial pellet was washed once, pelleted, 
and resuspended in labeling buffer [PBS pH 7.4 containing 1 mM CaCl2, 0.5 mM MgCl2, 
and 1.6 mM D-biotin (Sigma-Aldrich)]. Sulfo-NHS-LC-biotin (Pierce) was added (200 μM 
final concentration) to the bacterial suspension and incubated for 30 minutes on ice.  
The reaction was quenched by the addition of two volumes TNKCM (50 mM Tris, pH 
7.4, 100 mM NaCl, 27 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2) and incubated at room 
temperature for 10 minutes. Bacteria were pelleted, washed in TNKCM three times, and 
resuspended in detergent-free lysis buffer [50 mM Tris, pH 7.4, 1 mM MgCl2, with 
EDTA-free protease inhibitor cocktail (Roche)]. Bacteria were lysed by sonication, and 
intact unbroken bacteria were pelleted at 7,000 x g for 10 minutes. The supernatant was 
centrifuged at 40,000 x g for 30 minutes at 4°C. The supernatant was discarded and the 
pellet (corresponding to a membrane fraction) was washed three times in TKE (50 mM 
Tris pH 7.4, 150 mM KCl, 10 mM EDTA).  The pellet was solubilized in TKEZ [50 mM 
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Tris pH 7.4, 150 mM KCl, 10 mM EDTA, 2% Zwittergent 3-14 (Fluka), with EDTA-free 
protease inhibitor cocktail] for 1 hour at 4°C.  This preparation was centrifuged at 
100,000 x g for 1 hour at 4°C and the supernatant (predicted to be enriched in outer 
membrane proteins) was processed further as described below, to allow purification of 
biotinylated proteins.  A previous study demonstrated that these methods result in 
minimal labeling of a periplasmic protein (119). A control sample was processed in 
parallel using exactly the same procedures, except that Sulfo-NHS-LC-biotin was 
omitted from the labeling reaction.  
Biotinylation of surface-exposed H. pylori proteins using a carboxyl-reactive biotinylation 
reagent. 
 H. pylori was cultured as described for the biotinylation experiments above.  The 
bacterial pellet was washed in MES buffer (100 mM MES pH 6.0, 500 mM NaCl, 5 mM 
biotin), pelleted at 3,500 x g for 10 minutes and resuspended in MES buffer containing 2 
mM 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC, Pierce)  and 5 
mM N-hydroxysulfosuccinimide (S-NHS, Pierce). The reaction was incubated for 15 
minutes at 4°C. The pH was raised from 6.0 to 7.3 with 1 M sodium carbonate. Amine-
PEG3-biotin was added to the reaction (24 mM final concentration) and incubated for 2 
hours at 4°C. Two volumes of TNKCM (50 mM Tris, pH 7.4, 100 mM NaCl, 27 mM KCl, 
1 mM CaCl2, 0.5 mM MgCl2) were added to the reaction and incubated at room 
temperature for 10 minutes. Bacteria were pelleted, washed in TNKCM three times, and 
resuspended in detergent-free lysis buffer [50 mM Tris, pH 7.4, 1 mM MgCl2, with 
EDTA-free protease inhibitor cocktail (Roche)]. Bacteria were lysed by sonication, and 
intact unbroken bacteria were pelleted at 7,000 x g for 10 minutes. The supernatant was 
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centrifuged at 40,000 x g for 30 minutes at 4°C. The supernatant was removed and the 
total membrane pellet was washed three times in TKE (50 mM Tris pH 7.4, 150 mM 
KCl, 10 mM EDTA).  Outer membrane proteins were solubilized in TKEZ (50 mM Tris 
pH 7.4, 150 mM KCl, 10 mM EDTA, 2% Zwittergent 3-14 (Fluka), with EDTA-free 
protease inhibitor cocktail) for 1 hour at 4°C (72).  Insoluble proteins were pelleted by 
centrifugation at 100,000 x g for 1 hour at 4°C and the supernatant (containing outer 
membrane proteins) was processed further as described below.  A control sample was 
processed in parallel using exactly the same procedures, except that EDC, S-NHS, and 
amine-PEG3-Biotin were omitted from the labeling reaction. 
Purification of biotinylated proteins. 
 To purify biotinylated proteins from the preparations described above, the 
samples were diluted 10 times in phosphate buffer (100 mM NaPO4 pH 7.4, 150 mM 
NaCl). Monomeric avidin magnetic beads (Bioclone) were prepared according to the 
manufacturer’s instructions and equilibrated in washing buffer (100 mM NaPO4 pH 7.4, 
150 mM NaCl, 0.2% Zwittergent 3-14).  The sample was incubated with equilibrated 
beads at room temperature, and bound proteins were eluted from the beads with 100 
mM NaPO4 pH 7.4, 150 mM NaCl, 0.2% Zwittergent 3-14, 5 mM D-Biotin (Sigma) for 30 
minutes at room temperature. Eluted proteins were precipitated with a final 
concentration of 25% TCA.  
Bacterial subcellular fractionation. 
 H. pylori was grown on trypicase soy agar plates for 24 hours and then grown for 
20 hours in Brucella broth to late log phase, corresponding to an OD600 of approximately 
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0.8.  Bacteria were pelleted by centrifugation at 3,500 x g for 20 min at 4°C.  The 
bacterial cells were then fractionated as described previously (111). In brief, the 
bacterial pellet was washed in 10 mM Tris pH 8.0 and resuspended in 10 mM Tris pH 
8.0 with EDTA-free protease inhibitor cocktail. Bacterial were lysed by sonication. Intact 
bacteria were pelleted at 7,000 x g for 10 minutes. A total membrane fraction was 
collected by centrifuging the supernatant at 230,000 x g for 1 hour at 4oC.   Membrane 
proteins were solubilized with Triton X-100 buffer (10 mM Tris pH 8.0, 1% Triton X-100, 
EDTA-free protease inhibitor cocktail) for 30 minutes at 4°C.  This preparation was 
centrifuged at 230,000 x g for 45 minutes at 4°C, yielding a soluble fraction (which is 
predicted to be enriched in inner membrane proteins) and an insoluble fraction (which is 
predicted to be enriched in outer membrane proteins).  
Proteinase K treatment of intact bacteria. 
 H. pylori was grown on trypicase soy agar plates for 24 hours and then grown for 
20 hours in BB-FBS broth to late log phase, corresponding to an OD600 of approximately 
0.8.  Bacteria were pelleted by centrifugation at 3,500 x g for 20 min at 4°C.  Bacteria 
were then washed with PBS and resuspended in Tris buffer (50 mM Tris pH 7.4, 150 
mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM KCl). Proteinase K was added to bacterial 
suspensions (final concentrations of either 100 μg mL-1 at 22oC or 1 mg mL-1 at 4oC) 
and incubated for 30 min (111, 114, 124). PMSF was added to a final concentration of 2 
mM. Bacteria were pelleted and resuspended in Tris buffer with protease inhibitor 
cocktail (Roche). Bacteria were then lysed by sonication and intact cells were removed 
by centrifugation at 5,000 x g for 10 min. Total membranes were collected by 
centrifugation at 200,000 x g for 30 min at 4oC. Membrane pellets were washed in Tris 
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buffer and solubilized in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 
1% NP-40, 0.25% sodium deoxycholate) containing protease inhibitor cocktail (111, 
114, 124).  
Mass spectrometric analysis of samples. 
 To provide a comprehensive analysis of the protein content in samples, the 
samples were analyzed by multidimensional protein identification technology (MudPIT) 
(19, 78). Protein preparations were either run about 2 cm into a 10% Bis-Tris NuPAGE 
gel, stained with Colloidal Coomassie, and then subjected to in-gel trypsin digestion, or 
TCA-precipitated proteins were digested with trypsin in solution. MudPITs were 
performed essentially as described previously (87), using a ThermoFisher LTQ 
equipped with a nano-electrospray source and attached to an Eksigent 1D+ or 
Nanoacuity (Waters) HPLC unit with an autosampler. Peptide MS/MS spectra were 
acquired data-dependently with one full scan MS followed by 5 MS/MS scans.  Acidified 
peptides were loaded onto a 150 micron ID biphasic trapping column comprised of 4 cm 
strong cation exchange resin (LUNA 5 micron, Phenomonex) followed by 4 cm reverse 
phase resin (Jupiter 5 micron, 300 angstrom). The trapping column was then attached 
to a 20 cm (Jupiter 3 micron, 300 angstrom) 100 micron ID fused silica analytical 
column packed into a pulled nanospray tip. Preparations of biotinylated proteins and 
respective unlabeled controls were analyzed by 8-step MudPIT.  Preparations from the 
proteinase K experiment and cell fractions were analyzed by 11-step MudPIT. Salt 
pulses were performed by using the autosampler to inject 5 μl of ammonium acetate at 
0, 100, 150, 200, 300, 500, 750, and 1000 mM concentrations for the 8-step analyses 
used in analyzing the biotinylated preparations, and 0, 50, 75, 100, 150, 200, 250, 300, 
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500, 750, and 1000 mM for the 11-step analyses.  After each salt injection, peptides 
were separated using a 105 minute aqueous to organic gradient (2% to 35% acetonitrile 
(ACN) for all but the last step, which went to 98% ACN). Peptide MS/MS spectra were 
queried using SEQUEST (full tryptic specificity) and Myrimatch (semi-tryptic specificity) 
against an H. pylori strain 26695 database, to which both common contaminants and 
reversed versions of the proteins had been appended. For analyses of mass 
spectrometry data from protease susceptibility experiments, we restricted the analysis 
to peptides that could be uniquely matched to a single protein. For analyses of mass 
spectrometry results from all other experiments, we analyzed all peptides detected, 
including those that could be matched to more than one H. pylori protein. Resulting 
identifications were filtered to an estimated peptide and protein false discovery rate 
(FDR) less than 5% and collated by protein using IDPicker 3.0.  All subsequent 
analyses were performed in Excel and R. All reported proteins were identified based on 
detecting a minimum of 2 distinct peptides.  
Analysis of mass spectrometry data. 
 All experiments were done in triplicate and the resulting spectral data were 
merged prior to analysis (135). Proteins were identified as enriched in one set of 
preparations compared to another, based on both analysis of fold enrichment 
[comparing normalized ratios of numbers of assigned spectra, calculated using either 
QuasiTel model-generated rates or Rsc values, which both account for abundance of 
spectral counts when analyzing normalized data] and the statistical significance of 
differences in abundance of spectral counts assigned to each protein (using Fisher’s 
exact test with a Bonferonni correction) (76, 101). Criteria for identifying proteins that 
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were enriched in one set of samples compared to another were chosen based on 
comparative analysis of data for spectral proteins previously annotated as outer 
membrane proteins (likely to be surface-exposed) and data for proteins annotated either 
as ribosomal proteins, annotated inner membrane proteins, or other non-outer 
membrane proteins based on annotation (not likely to be surface-exposed) (Figure 2), 
(135).  The application of the selected cutoffs resulted in a protein false discovery rate 
of <10% (Figure 2). I then applied these same cutoff criteria in analysis of spectral data 
corresponding to all proteins identified in the respective preparations (135).  
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Figure 2. Criteria for identifying enriched proteins. To identify proteins enriched in 
each preparation of interest compared to a control or comparison preparation, I 
calculated the fold enrichment for each protein (based on analysis of spectral counts, 
using QuasiTel) and also calculated the statistical significance of differences in numbers 
of spectral counts assigned to each protein in the two preparations (using Fisher’s exact 
test with a Bonferonni correction).  The x axes indicate fold enrichment and the y axes 
indicate values corresponding to (1 – p value).  I then analyzed data for proteins 
annotated as outer membrane proteins compared to data for proteins predicted to have 
a non-surface-exposed localization. These analyses allowed us to choose appropriate 
criteria for identifying proteins that were enriched in one sample compared to another 
sample. False discovery rates were calculated by comparing a positive control group of 
proteins (annotated outer membrane proteins for panels A and B, or an expanded list of 
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putative outer membrane proteins selected based on previous studies and protein 
annotation for panel C) to a negative control group of proteins (27 ribosomal proteins for 
Biotin>Control and TM > CP, PP; or a set of predicted inner membrane proteins (IMP) 
that were selected based on previous studies and protein annotation)(135). For each 
analysis, I defined a p value of < 0.05 with Bonferonni correction as significant, and 
arbitrarily selected cutoffs for fold-enrichment to allow the identification of a maximum 
number of positive control proteins while limiting the false discovery rate to < 10%. 
Proteins were considered enriched if the numbers of assigned spectra were significantly 
higher in the preparation of interest compared to control preparations, and if there was a 
minimum fold enrichment compared to the respective counterpart. (A) Biotin compared 
to unlabeled control (Biotin > Control), (B) membrane proteins compared to soluble 
proteins (TM > CP, PP), (C) Triton X-100 insoluble proteins compared to Triton X-100 
soluble proteins (OM > IM). (D) Proteinase K-treated bacteria compared to non-treated 
bacteria (PK susceptible > PK non-susceptible).  Vertical line indicates the minimum 
levels of enrichment selected as cutoffs: Biotin > Control = 2, TM > CP, PP = 5.5, OM > 
IM = 2, PK susceptible > PK non-susceptible = 5.  
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Mapping of protein segments that are susceptible to proteinase K digestion. 
 To systematically identify sites within individual proteins that were susceptible to 
proteinase K digestion, I analyzed the spectral data from the proteinase K experiment 
described above (conducted at 4oC). Spectral coverage data from IDPicker 3.0 files 
were uploaded into R. For each protein to which peptides had been matched, I then 
quantified the spectral coverage at individual amino acid positions.  I analyzed all amino 
acid sites for which >5 assigned spectra were detected in the untreated control sample 
(designated as ‘residues available for analysis’), and restricted the analysis to proteins 
with >100 residues available for analysis.  Residues with a ≥5-fold greater number of 
assigned spectra in the untreated control samples compared to the protease-treated 
samples were designated as protease-susceptible sites. Residues with a <2-fold greater 
number of assigned spectra in the untreated control samples compared to the protease-
treated samples were designated as protease-non-susceptible sites. Criteria for the 
designation of protease-susceptible proteins were chosen based on a comparative 
analysis of annotated OMPs and proteins predicted to have an inner membrane, 
cytoplasmic, or periplasmic localization (indicated as “non-OMPs) (Figure 2) (135).    
Proteins with a normalized ratio of susceptible residues to non-susceptible residues of 
>5 and exhibiting a statistically significant increased ratio of susceptible residues to non-
susceptible residues (determined by Fisher’s exact test with Bonferroni correction) were 
considered susceptible to protease treatment (Figure 2) (135). 
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Results 
Identification of surface-exposed proteins. 
 To identify proteins localized on the surface of H. pylori, I used a cell-
impermeable amine-reactive biotin conjugation reagent to label surface-exposed 
proteins on intact bacterial cells. SDS-PAGE and silver staining of proteins purified from 
the biotinylated bacteria revealed the presence of numerous proteins (Figure 3A). In 
parallel, I generated a mock preparation of proteins purified from non-biotinylated 
bacteria. This unlabeled control preparation contained a relatively low abundance of 
proteins compared to the sample of purified biotinylated proteins (Figure 3A).  As a first 
step in analyzing and comparing these preparations, I immunoblotted the two samples 
with several available antisera.  CagA and UreA were equally abundant in both 
preparations, whereas Cag3, CagM, CagT and CagX were more abundant in the 
biotinyated preparations (Figure 3B). These results are consistent with an enrichment of 
specific proteins in the preparation of biotinylated proteins compared to the unlabeled 
control sample.  
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Figure 3.  Analysis of purified biotinylated proteins. (A) Biotinylated proteins were 
purified from biotinylated bacteria, and a control preparation was generated from non-
biotinylated bacteria. Equal volumes of each preparation were analyzed by silver 
staining. Specific bands were visible in the preparation of biotinylated proteins but not in 
the control preparation. (B) The preparations from panel A, as well as subcellular 
fractions, were immunoblotted with antisera to five proteins encoded by the cag PAI, 
UreA, and HspB.  Equal volumes of biotinylated and unlabeled control preparations 
were loaded into each lane, and standardized amounts of subcellular fractions (25 ug of 
total protein) were loaded into each lane.  CP,PP – soluble proteins predicted to have a 
cytoplasmic or periplasmic localization; TM, insoluble proteins corresponding to a total 
membrane preparation; IM, Triton-soluble membrane proteins, predicted to have an 
inner membrane localization; OM, Triton-insoluble membrane proteins, predicted to 
have an outer membrane localization.  
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I generated three independent preparations of the biotinylated and unlabeled 
control samples, and analyzed the protein contents of these samples by multi-
dimensional protein identification technology (MudPIT). Consistent with the results of 
SDS-PAGE and silver staining, the total number of spectra confidently matched to H. 
pylori proteins (spectral counts) was about 5 times higher in analyses of the biotinylated 
preparations than in analyses of the control preparations (Table 2) (135).  In total, I 
identified >500 H. pylori proteins in these samples (135). The detection of numerous 
proteins in the control preparations despite very few bands being visible on the silver-
stained SDS-PAGE gel is attributed to the high sensitivity of the mass spectrometric 
detection methods.  I employed a statistical approach (based on analysis of spectral 
counts) to compare the biotinylated preparations with the unlabeled control 
preparations, and identified 85 proteins that were significantly enriched in the 
biotinylated preparations compared to the control preparations  (Table 2, Figure 2).   
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Table 2. Summary of mass spectrometry data 
Sample 
Number of 
assigned 
spectral 
Number of 
proteins 
detectedm 
Biotina 82,844 1,055 
Controlb 16,009 941 
Biotin>Controlc NA 85 
TMd 90,604 1,120 
CP,PPe 78,773 1,066 
TM>CP,PPf NA 192 
OMg 64,478 1,095 
IMh 74,320 1,114 
OM>IMi NA 156 
Untreated 4oCj 92,644 1,063 
Untreated RTj 75,482 1,056 
PK 4oCj 100,521 1,064 
PK RTj 103,021 1,063 
Untreated>PK 4oCk NA 7 
Untreated>PK RTk NA 6 
 
abiotinylated preparations  
bunlabeled control preparations  
csubset of proteins that were significantly enriched in biotinylated preparations 
compared to unlabeled control preparations 
dinsoluble proteins (in the absence of detergent), predicted to localize to the total 
membrane (TM) compartment  
esoluble proteins (in the absence of detergent), predicted to localize to the cytoplasmic 
and periplasmic compartments (CP, PP) 
fsubset of proteins that were significantly enriched in the insoluble preparations (TM) 
compared to soluble preparations (CP, PP)  
gTriton X-100-insoluble proteins, predicted to localize to the outer membrane (OM) 
compartment  
hTriton X-100-soluble proteins, predicted to localize to the inner membrane (IM) 
compartment  
i subset of proteins that were significantly enriched in the Triton X-100-insoluble 
preparations compared to the Triton X-100-soluble preparations  
j Intact bacteria were incubated in buffer or treated with proteinase K (PK) at 4oC or 
room temperature (RT). 
k subset of proteins for which assigned peptides were detected at significantly higher 
levels in untreated preparations than in proteinase K-treated preparations.  
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l Results represent the sum of assigned ms/ms spectra, based on analysis of three 
combined biological replicates.  
m Results represent the total number of identified proteins, based on analysis of three 
combined biological replicates. 
NA, not applicable. 
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I also used biophysical methods independent of biotin labeling to identify proteins 
associated with the H. pylori outer membrane. This approach was based on the 
reasoning that most surface-exposed proteins are likely to be associated with the 
bacterial outer membrane. As a first step, I used detergent-free conditions to generate 
preparations of soluble H. pylori proteins (predicted to contain cytoplasmic and 
periplasmic compartments) and insoluble H. pylori proteins (predicted to be derived 
from both inner and outer membranes, subsequently referred to as the total membrane 
fraction). Then I fractionated the total membrane preparation based on differential 
protein solubility in Triton X-100, which allows separation of inner membrane proteins 
and outer membrane proteins (111).  Immunoblotting of these fractions with the same 
antisera used the analysis of the biotinylated samples in Figure 3B revealed that four 
Cag proteins (Cag3, CagM, CagT and CagX) were more abundant in the total 
membrane fraction than in the cytoplasmic/periplasmic fraction, and also more 
abundant in the outer membrane fraction than in the inner membrane fraction (Figure 
3B). I generated three independent preparations of each fraction, and the protein 
composition of these samples was analyzed by MudPIT.  I identified 191 proteins that 
were significantly enriched in the total membrane preparations compared to the soluble 
protein preparations (Table 2 and Figure 2) (135), and I identified 155 proteins that were 
significantly enriched in the Triton-insoluble outer membrane fractions compared to the 
Triton-soluble inner membrane fractions (Table 2, and Figure 2) (135).   
To evaluate the efficacy of the procedures described above for enrichment of 
putative outer membrane proteins, I analyzed the presence in each preparation of 
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proteins previously predicted by Tomb et al. to be outer membrane proteins (“annotated 
OMPs”) (132) and subsequently classified as Hop or Hop-related proteins (3).  There 
was a significant enrichment of proteins with an outer membrane protein annotation in 
preparations of biotinylated proteins compared to preparations of control (non-
biotinylated) proteins (p < 0.0001) (Figure 4).  Similarly, there was an enrichment in 
annotated OMPs when comparing the total membrane preparations with the soluble 
protein preparations (cytoplasmic/periplasmic proteins) (p < 0.0001), and when 
comparing the outer membrane preparations with the inner membrane preparations (p < 
0.0001) (Figure 4).  These analyses indicated that, as expected, each of the 
experimental approaches resulted in an enrichment of annotated outer membrane 
proteins.     
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Figure 4.  Enrichment of proteins with an “outer membrane protein” annotation. 
The proportion of spectra and proportion of proteins annotated as outer membrane 
proteins were analyzed for each set of preparations. (A) Black bars indicate the 
proportion of spectral counts in each preparation that were attributed to proteins 
previously annotated as Hop or Hor outer membrane proteins. (B) Black bars indicate 
the proportion of proteins identified in each preparation that were previously annotated 
as Hop or Hor outer membrane proteins. CP, PP: Soluble proteins, predicted to be 
localized to cytoplasmic and periplasmic compartments; TM: insoluble proteins 
predicted to be localized to membranes; IM: Triton X-100-soluble proteins, predicted to 
localize to the inner membrane; OM: Triton X-100-insoluble proteins, predicted to 
localize to the outer membrane; Control: unlabeled control used in biotinyation 
experiment; Biotin: preparation of purified biotinylated proteins. Biotin > Control: proteins 
identified as enriched in the biotinylation preparation compared to control. TM > CP, PP: 
proteins enriched in the TM preparation compared to the CP, PP preparation. OM > IM: 
proteins enriched in the OM fraction compared to the IM fraction. All Three: proteins 
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meeting three criteria consistent with outer membrane localization (enriched in the 
biotinylated, TM and OM preparations, compared to respective controls). All data 
represent the combined results from three independent experiments. ****, p < 0.001 for 
the indicated comparisons (Fisher’s Exact test). Values for the set of proteins 
designated “All Three” in section (A) were significantly higher than values for all other 
protein sets (p < 0.001). 
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Proteins meeting multiple criteria for surface-exposed outer membrane localization. 
 I next sought to identify proteins that met multiple criteria for surface-exposed 
outer membrane localization, thereby providing stronger evidence compared to the use 
of only a single method. Specifically, I sought to identify proteins that met three criteria: 
(i) significantly enriched in the biotinylated preparations compared to the control (non-
biotinylated) preparations, (ii) significantly enriched in the total membrane preparation 
compared to the soluble fraction, and (iii) significantly enriched in the Triton-insoluble 
outer membrane fraction compared to the Triton-soluble inner membrane fraction.  
Thirty nine proteins (localized in the center of the Venn diagram shown in Figure 5A) 
met all three of these criteria (Table 3).  In an analysis of the detected peptides 
corresponding to this set of 39 proteins, 66% of the spectra were assigned to proteins 
previously annotated by Tomb et al. as outer membrane proteins (132) (Figure 5B), 
which is significantly higher than the corresponding values for any of the individual 
preparations (Figure 4). Thirteen of these 39 proteins were annotated by Tomb et al. as 
predicted OMPs (corresponding to 12 Hop and 1 Hop-related or Hor protein) (132), and 
20 were annotated by Alm et al. as predicted OMPs [including three annotated as 
iron(III) dicitrate transport (FecA) proteins, an iron-regulated FrpB protein  and the 
VacA-like protein FaaA (HP0609/0610)] (3, 114).  The set of 39 proteins also includes 
numerous proteins not previously annotated as OMPs. These include three Cag 
proteins (Cag3, CagM, and CagT), each of which is required for the function of the cag 
T4SS that translocates the effector protein CagA into gastric epithelial cells (cag T4SS) 
(35),  several annotated as lipoproteins (including Lpp20 and HP1571) (66), two 
homologs of the flagellar sheath adhesin HpaA (HP0410 and HP0492) (27, 119), a 
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protein annotated as “protective surface antigen D15” which corresponds to an outer 
membrane assembly protein BamA ortholog (HP0655), a secreted serine protease 
(HtrA, HP1019)(15, 50), a protein annotated as a conserved secreted protein or peptidyl 
prolyl cis-trans isomerase (HP0977), a plasminogen-binding protein (PgbB, HP0863) 
(61), and several proteins identified annotated as “hypothetical proteins” (Table 3, 
Figure 5C).  
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Figure 5. Use of multiple criteria to identify surface-exposed outer membrane 
proteins.  A) Venn diagram of proteins identified as enriched in the biotinylated 
preparation compared to the control preparation (Biotin > Control), enriched in the total 
membrane preparation compared to the soluble fraction (TM > CP, PP), and enriched in 
a Triton-insoluble preparation compared to a Triton-soluble preparation (OM > IM).  
Thirty nine proteins met all three criteria. B-C) Characteristics of the 39 proteins in the 
center segment of (A), based on proportion of spectral counts (B) or proportion of 
annotated proteins in each class (C). Annotated OMPs represent Hop and Hor OMPs. 
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Table 3: Proteins meeting multiple criteria for surface-exposed outer membrane 
proteinsa 
 
Original annotation 
Alternate 
names Gene number 
outer membrane protein (Omp2) HopD HP0025 
hypothetical protein  HP0036 
hypothetical protein  HP0120 
outer membrane protein (Omp4) HorB HP0127 
outer membrane protein (Omp7) HopF/HopX HP0252 
hypothetical protein  HP0358 
putative neuraminyllactose-binding hemagglutinin homolog (HpaA)  HP0410 
outer membrane protein (Omp12) HopJ HP0477 
lipoprotein, putative HpaA HP0492 
cag pathogenicity island protein (Cag3) Cag3 HP0522 
cag pathogenicity island protein (Cag12) CagT HP0532 
cag pathogenicity island protein (Cag16) CagM HP0537 
penicillin-binding protein 1A (PBP-1A)  HP0597 
membrane fusion protein (MtrC) HefB HP0606 
hypothetical proteinb FaaA HP0609b 
toxin-like outer membrane proteinb FaaA HP0610b 
outer membrane protein (Omp13) HopH/OipA HP0638 
protective surface antigen D15 BamA HP0655 
iron(III) dicitrate transport protein (FecA) FecA-1 HP0686 
lipoprotein, putative  HP0746 
iron(III) dicitrate transport protein (FecA) FecA-2 HP0807 
lipoprotein, putative  HP0838 
lipoprotein, putative PgbB HP0863 
outer membrane protein (Omp19) BabB/HopT HP0896 
outer membrane protein (Omp20) HopC/AlpA HP0912 
outer membrane protein (Omp21) HopB/AlpB HP0913 
outer membrane protein (Omp22) HopK HP0923 
conserved hypothetical secreted protein  HP0977 
lipoprotein, putative  HP1002 
serine protease (HtrA)  HP1019 
outer membrane protein (Omp25) HopI HP1156 
outer membrane protein (Omp26) HopL HP1157 
hypothetical protein  HP1173 
outer membrane protein (Omp27) HopQ HP1177 
outer membrane protein (Omp28) BabA/HopS HP1243 
paralysed flagella protein (PflA)  HP1274 
iron(III) dicitrate transport protein (FecA) FecA-3 HP1400 
membrane-associated lipoprotein (Lpp20)  HP1456 
iron-regulated outer membrane protein (FrpB) FrpB-3 HP1512 
rare lipoprotein A (RlpA)  HP1571 
 
a These proteins correspond to 39 that are depicted in the center of the Venn diagram 
shown in Figure 5A. 
b HP0609 and HP0610 were originally annotated as two separate proteins, but 
correspond to a single protein (VacA-like protein FaaA).  
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I also analyzed the proteins that met only two criteria for outer membrane 
localization, corresponding to relevant segments of the Venn diagram in Figure 5A.  
One subset of 18 proteins (enriched in the biotinylation preparations and the total 
membrane preparations, but not in the Triton-insoluble membrane preparations) 
included six annotated OMPs (BabC or HopU, HP0317; HomA, HP0710; HopM, 
HP0227; HopA, HP0229; HorF, HP0671; HopN, HP1342) and HpaA (a flagellar sheath 
adhesin, HP0797) (60).  A high proportion of the proteins in the other segments of the 
Venn diagram (Figure 5A) corresponded to proteins predicted to have an intracellular 
localization, and these probably represent false positive results. 
Collectively, these experiments detected numerous proteins on the surface of H. 
pylori that had previously been predicted to have outer membrane localization 
(“annotated OMPs”), as well as additional proteins that were not previously predicted to 
be localized on the H. pylori surface.  The evidence for surface localization is strongest 
for the set of proteins meeting multiple criteria for surface-exposed outer membrane 
localization, depicted in the center of the Venn diagram in Figure 5A and Table 3.  
 
Immunogold EM analysis of CagT. 
 To provide further evidence for the surface-exposed localization of proteins not 
previously annotated as OMPs, I selected one of the proteins that met multiple criteria 
for outer membrane localization (CagT) and undertook further analysis of this protein by 
immunogold electron microscopy.  In immunogold labeling experiments with an anti-
CagT antiserum, I detected a significantly greater number of gold particles on the 
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surface of wild-type bacteria than on the surface of Δcag PAI mutant bacteria, which fail 
to produce CagT (p < 0.0001) (Figure 6). In images of the wild-type bacteria, multiple 
gold particles were often clustered together, which suggests that CagT is non-randomly 
distributed on the bacterial surface.  These immunogold labeling studies corroborate the 
surface localization of CagT, and provide further validation of the experimental 
approaches used in this study for the identification of surface-exposed proteins.  
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Figure 6. Localization of CagT by immunogold EM analysis. (A-C) H. pylori strains 
were immunolabeled with rabbit antiserum to CagT, followed by secondary antibodies 
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conjugated to 10 nm gold particles.  Panels A and B, wild-type strain.  Panel C, Δcag 
PAI mutant strain (ΔPAI).  Higher magnification images of the regions in boxes, 
containing a high density of gold particles, are shown at right. Arrowheads designate 
additional gold particles.   D) Immunogold labeling of the WT strain using secondary 
antibodies conjugated to gold particles, without primary antiserum.  The number of gold 
particles detected on WT bacteria was significantly higher than the number detected on 
the cag ΔPAI mutant strain (mean 3.6 gold particles per WT cell and 1.8 gold particles 
per cag ΔPAI mutant cell, based on analysis of >200 bacteria of each type, p-value < 
0.0001, Welch two sample t-test). Bars, 500 nm. 
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Experimental evidence of amino-terminal signal sequence cleavage. 
 Many surface-exposed proteins are predicted to undergo cleavage of an N-
terminal signal sequence during Sec-dependent export across the inner membrane. To 
experimentally identify surface-exposed proteins that underwent cleavage of amino-
terminal signal sequences, I analyzed the spectral data from the biotinylation 
experiments and sought to identify peptides that had been generated by non-tryptic 
cleavage events occurring near the amino-termini of proteins. Fourteen of the 39 
surface-exposed proteins shown in Table 3 showed evidence of amino-terminal non-
tryptic cleavage events consistent with Sec-dependent signal sequence processing 
(Table 4) (135).  An alignment of these sequences, relative to the sites of non-tryptic 
cleavage, is shown in Figure 7.  The consensus sequence includes a stretch of 
approximately 10 uncharged or hydrophobic residues upstream of the cleavage site, a 
semi-conserved leucine at position -3, and an alanine at position -1.   An acidic patch of 
1-3 residues was detected immediately downstream from the cleavage site  (135). 
Interestingly, the signal peptide prediction software SignalP 4.1 (109) predicted the 
existence of only seven of these 14 cleavage sites, and for one of the proteins (HP1156, 
HopI), the cleavage site predicted by SignalP differed by one amino acid position 
compared to what was experimentally detected. This discrepancy suggests that the 
currently available signal peptide prediction software is not optimally designed for 
analysis of signal peptides in ε-Proteobacteria such as H. pylori.  
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Table 4. Detected amino-terminal non-tryptic cleavage events in the three 
biotinylated preparations (a)  
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 (a) Three biotinylated preparations were analyzed for spectral coverage. Fourteen of 
the 39 surface-exposed proteins (Table 3) were found to undergo non-tryptic cleavage 
at the amino-terminus, consistent with sec-dependent cleavage.      
(b) Amino acid number, "/" indicates cleavage     
(c ) Amino acid sequence around cleavage, "-" indicates cleavage     
(d) Amino acid number of predicted cleavage site determined by SignalP, "NO" 
indicates no sec-dependent cleavage predicted 
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Figure 7.  Experimentally detected sites of signal peptide cleavage. A) Identified 
peptides in the preparations of biotinylated proteins that corresponded to non-tryptic 
cleavage events and that could be matched to sites near the N-termini of proteins, 
suggesting the occurrence of signal peptide cleavage.  This analysis was restricted to 
peptides that could be matched to a single protein.  Amino-terminal non-tryptic cleavage 
was detected for 14 of the 39 surface-exposed proteins shown in Tables 3 and 4.   In 
the alignment, the numbering of positions is relative to the detected non-tryptic cleavage 
site. B) Aligned 14 confirmed signal sequences and amino-terminal peptides from 
multiple other Gram-negative bacterial species from Signal Peptide Website 
(http://signalpeptide.de). Sequences were then aligned using WebLogo 
(weblogo.berkeley.edu).  
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Multiple classes of C-terminal motifs in surface-exposed proteins. 
 Targeting of proteins to the outer membrane is often dependent on the presence 
of a C-terminal motif required for interaction with the β‐barrel assembly machinery 
(Bam) complex (13, 45). Therefore, I analyzed the C-terminal sequences of the 39 
surface-exposed proteins shown in Table 3.  The most commonly identified amino acids 
at the C-terminal position were phenylalanine (n = 16), lysine (n = 9) or tyrosine (n = 5) 
(135).      
There were several similarities in the C-terminal sequences of the proteins 
terminating in phenylalanine (F) or tyrosine (Y).   Specifically, 13 of the 39 surface-
exposed proteins shown in Table 3 contain closely related C-terminal sequences 
characterized by a conserved tyrosine at the -5 position, a conserved arginine at the -13 
position, either a valine (7 proteins) or phenylalanine (6 proteins) at position -9, and 
semi-conserved tyrosines at position -8 (11 proteins) and -15 (10 proteins) (Figure 8).  
Thus, the consensus C-terminal motif for these proteins is [Y/F X R XXX V/F Y XX Y 
XXX F/Y], and three of these proteins (HopQ, BabA, and BabB) contain an identical C-
terminal motif (VYLNYVFAY). All 13 of these C-terminal sequences contain hydrophobic 
residues at the -1, -3, -5, -7, -8, -9 and -15 positions, which is consistent with a motif 
that allows insertion of proteins into the outer membrane through a BamA (or Omp85)-
dependent process (13, 128).  Twelve of the 13 proteins containing this motif are 
classified as Hop proteins and one as a Hop-related protein (HorB, HP0127).  Eight of 
the 21 proteins with C-terminal phenylalanines or tyrosines, including the VacA-like 
protein FaaA, contain C-terminal sequences that are somewhat different from the 
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consensus described above, but still contain hydrophobic residues at the -3, -5, -7, and 
-9 positions.  
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Figure 8.  Analysis of a conserved C-terminal motif.  A) Among the 39 surface-
exposed proteins shown in Table 3, 15 contain a distinctive C-terminal motif, 
characterized by conserved residues at positions -15, -13, -9, -5 and -1 (135).  Numbers 
correspond to the distance from the carboxyl-terminus. B) 100 randomly selected OMPs 
[collected from OMPdb (ompdb.org)] from other Gram-negative bacterial species were 
aligned. Sequences were aligned using WebLogo (weblogo.berkeley.edu). 
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Eighteen of the 39 proteins did not contain a C-terminal phenylalanine or tyrosine; in 
nine cases the C-terminal amino acid was lysine and in two cases the C-terminal amino 
acid was arginine.  There was no apparent conservation of C-terminal sequences 
among the 9 proteins with C-terminal lysines or among the larger set of 18 proteins 
terminating in amino acids other than phenylalanine or tyrosine.   However, many of 
these had C-terminal segments that were characterized by an abundance of basic 
residues (lysine and arginine)  (135).  Interestingly, several of these were previously 
annotated as lipoproteins.  I hypothesized that the amine-reactive biotinylation reagent 
might preferentially label these C-terminal basic residues, leading to an increased 
representation of these proteins in the preparation of purified biotinylated proteins. To 
address this possibility, I biotinylated surface-exposed proteins with a cell-impermeable 
carboxyl-reactive biotinylation reagent, and then purified and analyzed the biotinylated 
proteins. By using this approach, I identified 32 proteins that were significantly enriched 
in the biotinylated preparation compared to the unlabeled control (135). Twenty-seven 
of these 32 proteins were also identified as surface-exposed in experiments using the 
amine-linked biotinylation method (Figure 9). Thus, the surface-exposed proteins 
identified when using a carboxyl-reactive biotinylation reagent were similar to those 
identified when using the amine-reactive biotinylation reagent. Eight of the 27 surface-
exposed proteins identified using both methods terminated in either a lysine or arginine, 
and the proportion of surface-exposed proteins terminating in either lysine or arginine 
was similar in experiments using the two methods (3 of 32 with the carboxyl-reactive 
method and 9 of 85 with the amine-reactive method). This provides evidence that the 
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proteins identified using the amine-linked biotinylation approach were not identified 
simply as a consequence of preferentially labeling C-terminal basic residues. 
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Figure 9. Comparison of surface-exposed proteins identified by carboxyl-reactive 
biotinylation compared to amine-reactive biotinylation. In experiments with an 
amine-reactive biotinylation reagent, I identified 85 proteins that were significantly 
enriched in the biotinylated preparation compared to a control preparation (135). In 
experiments with a carboxyl-reactive biotinylation reagent, I identified 32 proteins that 
were significantly enriched in the biotinylated preparation compared to a control 
preparation (135). The Venn diagram compares proteins identified using these two 
biotinylation methods, as well as the set of 39 proteins shown in Table 3. The proteins 
identified in experiments with the carboxyl-reactive biotinylation reagent were similar to 
the proteins identified in experiments using an amine-reactive biotinylation reagent. 
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Susceptibility of surface-exposed proteins to proteinase K digestion and cell surface 
topology of surface-exposed proteins. 
 I next undertook experiments designed to assess the susceptibility of surface-
exposed proteins on intact bacteria to digestion by an exogenous protease.  These 
experiments provided an additional approach for localizing specific proteins to the 
surface of H. pylori, and also allowed us to test the hypothesis that specific groups of 
surface-exposed OMPs might differ in susceptibility to proteolytic cleavage. I treated 
intact bacteria with proteinase K under conditions previously shown to preferentially 
digest surface-exposed proteins but not intracellular proteins (111, 124).  I then used 
MudPIT to identify proteins for which there were significantly reduced numbers of 
assigned spectra detected in protease-treated bacteria compared to control bacteria.  I 
identified 7 such proteins that were highly susceptible to proteolysis: VacA (HP0887), 
BabA (HP1243), BabB (HP0896), BabC (HopU, HP0317), HopQ (HP1177), HomA 
(HP0710), and HomD (Table 5) (135).  Three of which (BabA, BabB, and HopQ) were 
identified using the biotinylation and fractionation methods. Proteinase K treatment did 
not cause any significant reduction in the abundance of peptides originating from inner 
membrane proteins, such as FixO (HP0145) and FtsH (HP1069) (135).  The results 
were similar in experiments conducted at 4oC and at 22oC (Table 5).     
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Table 5. Surface-exposed proteins highly susceptible to proteinase K digestion, 
based on total assigned spectraa 
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a Intact H. pylori were incubated with proteinase K at 4oC or 22oC, and the treated 
bacteria (as well as untreated controls) were then analyzed by MudPIT.    
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 b The combined results of three independent experiments for each condition (untreated 
or proteinase K-treated)  are shown.   
 c Results for proteinase K-treated bacteria were compared with results for untreated 
bacteria, using Fisher’s exact test with  Bonferonni multiple test correction. 
 d The magnitude of changes in protein abundance in response to proteinase K 
digestion was calculated based on analysis of 2𝑅𝑆𝐶. 
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The methodology described above, based on analysis of all spectra assigned to 
individual proteins, allowed us to identify proteins that were highly susceptible to 
proteolytic digestion by an exogenous protease, but this is probably not a sensitive 
approach for identifying proteins that undergo proteolysis at relatively few sites. 
Therefore, I systematically analyzed the protein coverage of peptides with assigned 
spectra for each detected protein at the level of individual amino acids, which permitted 
a more in-depth assessment of sites where proteins had undergone proteolysis.  The 
identification of protease-susceptible sites using this approach is illustrated in the top 
panel of Figure 10.  Using this approach, six of the seven proteins described above 
were identified as susceptible to proteolytic digestion, and 9 additional protease-
susceptible proteins were identified (Figure 10 and Table 6).  8 proteins were also 
identified using biotinylation and fractionation (AlpA, AlpB, BabA, BabB, HopF, HopQ, 
OipA, and FaaA). HomD, identified as protease-susceptible in the earlier analysis 
(Table 5), was excluded from the current analysis  because the mass spectral data did 
not meet the inclusion criteria. Thirteen of the 15 protease-susceptible proteins met 
multiple criteria for surface-exposed localization in the earlier biotinylation and cell 
fractionation experiments (135). Additionally, VacA was identified as susceptible to 
proteinase K treatment. The other protein exhibiting evidence of protease susceptibility 
(cell division inhibitor MinD) is presumed to represent a false positive result. A 
systematic comparison of the protease-susceptibility of annotated OMPs detected in the 
proteomic analysis revealed that the majority of Hop proteins were susceptible to 
proteolytic digestion, but several Hop proteins (HopJ, HopK, HopE, HopG) were 
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resistant (Table 7).  In comparison to Hop proteins, the Hof and Hor families of OMPs 
were relatively resistant to extracellular protease digestion (Table 7).   
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Figure 10. Susceptibility of surface-exposed proteins to proteinase K treatment. 
Intact H. pylori cells were treated with proteinase K (1 mg mL-1) or buffer control at 4°C, 
and were then analyzed by MudPIT.  Three experiments were performed and the 
results were merged.  I then analyzed the assigned spectra for each detected protein at 
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the level of individual amino acids, and sites susceptible to proteolytic cleavage or 
resistant to proteolytic cleavage were identified, based on criteria defined in Methods. 
Blue bars (top half of graphs) depict numbers of assigned spectra from experiments 
with control (untreated) bacteria,  red bars (bottom half of graphs) depict numbers of 
assigned spectra from experiments with proteinase K-treated bacteria, and orange lines 
indicate the ratio of assigned spectra untreated compared to protease-treated bacteria.  
Data for 5 representative proteins are shown. In the top panel, the green shading 
illustrates protease-susceptible regions in BabA (exhibiting a >5 fold difference in 
abundance of spectral counts when comparing untreated bacteria and protease-treated 
bacteria) and the pink shading illustrates protease-resistant regions (exhibiting a < 2-
fold difference in abundance of spectral counts). The designation of protease-
susceptible or protease-resistant regions was restricted to residues for which >5 
assigned spectra were detected in the untreated samples. The N-terminal portions of 
BabB, HomA and VacA were highly susceptible to protease digestion, whereas 
intracellular proteins such as the cytochrome c oxidase subunit FixO (HP0145) and the 
cell division protein FtsH were resistant to protease digestion.  
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Table 6. Proteins identified as susceptible to extracellular proteinase K digestion, 
based on analysis of individual amino acid sites 
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a Total number of amino acids in the annotated gene. 
bTotal number of amino acids with >5 assigned spectra in the untreated samples. 
c Total number of amino acids with >5-fold more assigned spectra in the untreated 
samples compared to proteinase K treated samples. 
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d Ratio of PK susceptible residues compared to  non-susceptible residues normalized 
by total residues for each category identified. 
e HP0609 and HP0610 were originally annotated as two separate proteins, but 
correspond to a single protein (VacA-like protein FaaA).  
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Table 7. Protease susceptibility of annotated OMPs 
OMP 
Gene 
Number 
Number Amino Acids 
Length 
# residues available 
for analysis
a
 
# residues susceptible 
to protease
b
 
% residues susceptible 
to protease
c 
Hop Family 
    
HopH HP0638 305 120 31 25.83 
HopJ HP0477 367 129 0 0 
HopK HP0923 369 129 0 0 
HopE HP0706 273 162 0 0 
HopL HP1157 1230 221 34 15.38 
HopG HP0254 431 233 0 0 
HopI HP1156 696 259 46 17.76 
HopB/AlpB HP0913 529 273 135 49.45 
HopA HP0229 483 283 197 69.61 
HopF HP0252 487 296 85 28.72 
HopM HP0227 691 356 143 40.17 
HopN HP1342 691 356 143 40.17 
HopC/AlpA HP0912 515 360 208 57.78 
HopD HP0025 711 436 52 11.93 
HopT/BabB HP0896 708 442 92 20.81 
HopS/BabA HP1243 733 444 190 42.79 
HopU/BabC HP0317 745 480 157 32.71 
HopQ HP1177 641 495 367 74.14 
Hop-Related Family 
    
HorI HP1113 277 24 0 0 
HorC HP0324 254 77 20 25.97 
HorE HP0472 186 85 0 0 
HorL HP1395 242 85 20 23.53 
HorF HP0671 270 123 0 0 
HorB HP0127 286 125 0 0 
HorJ HP1469 248 131 0 0 
HorH HP1107 230 132 25 18.94 
HorK HP1501 388 221 0 0 
Hom Family 
    
HomC HP0373 700 25 25 100 
HomD HP1453 746 26 26 100 
HomA HP0710 660 283 205 72.44 
Hof Family 
    
HofD HP0487 480 87 0 0 
HofF HP0788 499 94 0 0 
HofG HP0914 514 177 0 0 
HofB HP1083 479 266 10 3.76 
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HofC HP0486 528 326 0 0 
HofE HP0782 455 0 0 0 
a Total number of amino acids with >5 assigned spectral in the untreated samples. 
b Total number of amino acids with >5-fold more assigned spectra in the untreated 
samples compared to proteinase K-treated samples. 
c Percentage of total number of amino acids with ≥5 assigned spectra in the untreated 
samples with ≥5-fold more assigned spectra in the untreated samples compared to the 
proteinase K-treated samples. 
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In an analysis of the regions within individual proteins that were susceptible or 
resistant to proteolysis, I noted that many annotated OMPs (especially those in the Hop 
family) were highly susceptible to protease digestion within the amino-terminal portion of 
the protein (comprising roughly two-thirds of the entire length of the protein), whereas 
the carboxy-terminal regions of these proteins were protease-resistant. This result was 
observed for 10 proteins (BabA, BabB, BabC, HopQ, HomA, HopA, HopM, HopN, AlpA, 
and AlpB) (Figures 10 and 11 and data not shown). The protease-resistant C-terminal 
regions of these proteins ranged from about 150 to 250 amino acids in length. Analysis 
of these proteins with the β-barrel prediction program BOCTOPUS predicts that the C-
terminal 160-300 amino acids of these proteins correspond to multiple trans-membrane 
β strand segments consistent with a β-barrel structure and that predicted trans-
membrane segments are absent or infrequently present elsewhere within these proteins 
(Figure 11). These data suggest that most of the protease-susceptible OMPs contain a 
large protease-susceptible extracellular domain exported beyond the outer membrane, 
and a protease-resistant β-barrel domain at the C-terminus.  
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Figure 11. Resistance of predicted β-barrel regions to digestion by proteinase K.  
This Figure shows an analysis of the protease-susceptibility of 4 H. pylori OMPs, using 
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the approach shown in Figure 10.  Blue bars (top half of graphs) depict numbers of 
assigned spectra from experiments with control (untreated) bacteria and red bars 
(bottom half of graphs) depict numbers of assigned spectra from experiments with 
proteinase K-treated bacteria.  The green shading illustrates protease-susceptible 
regions (exhibiting a >5 fold difference in abundance of spectral counts when comparing 
untreated bacteria and protease-treated bacteria) and the pink shading illustrates 
protease-resistant regions (exhibiting a < 2-fold difference in abundance of spectral 
counts). The designation of protease-susceptible or protease-resistant regions was 
restricted to residues for >5 assigned spectra were detected in the untreated samples. 
The locations of trans-membrane β strands were predicted using the program 
BOCTOPUS, and are shown at the top of each panel (grey indicates predicted trans-
membrane β-strands).  A large N-terminal portion of HopQ is highly susceptible to 
proteolytic digestion, whereas the C-terminal portion of HopQ is resistant to proteolytic 
digestion. The other 3 OMPs (HopE, HorB, and HofC) are relatively resistant to 
proteolysis.  The resistant C-terminal region of HopQ corresponds to a region predicted 
by BOCTOPUS to have multiple trans-membrane β strands, consistent with a β-barrel 
structure.  Three protease-resistant OMPs (HopE, HorB and HofC) are each predicted 
to have predominantly β-barrel structure. 
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Discussion 
 In this study, I used multiple complementary methods to identify and analyze 
proteins localized on the surface of H. pylori.  I identified 39 proteins that met 3 criteria 
for surface localization or outer membrane localization (i.e. identification by biotinylation, 
enriched in a membrane fraction compared to soluble fraction, and enriched in a Triton-
insoluble outer membrane fraction compared to a Triton-soluble inner membrane 
fraction), thereby providing stronger evidence for surface localization compared to the 
use of only a single method.  Among these 39 proteins, many were previously known or 
predicted to be localized on the bacterial surface, whereas others were not previously 
known to be surface-exposed or associated with the outer membrane.  
My primary method involved biotinylation of surface-exposed proteins with a 
membrane-impermeable biotinylation reagent.  A potential concern with biotinylation-
based methods is the possibility that periplasmic or inner membrane proteins might be 
labeled, but a previous study showed that the approach used in this study results in 
minimal labeling of the abundant E. coli periplasmic protein MalE (119).  The 
biotinylation experiments allowed us to identify 85 putative surface-exposed H. pylori 
proteins (135). Eighteen putative surface-exposed proteins were identified in a previous 
study that used similar biotinylation-based methodology (119).  Three surface-exposed 
proteins were identified in both the current study and the previous study: an HpaA-like 
protein (HP0410), CagM, and the secreted serine protease HtrA (15, 50, 119).  There 
were several differences when comparing the methodology of the current study with that 
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used in a previous study (119). First, the current study used a MudPIT-based 
methodology for identifying proteins, whereas the previous study used 2D gel-based 
methods; limitations in the use of 2D gel methods for detection of membrane proteins 
may account for the detection of relatively few annotated OMPs in the previous study.  
Second, the current study compared preparations of biotinylated proteins with control 
non-biotinylated preparations, which allowed the exclusion of proteins that interacted 
non-specifically with the beads used in the purification process.  Third, the current study 
used monomeric avidin-coated magnetic beads instead of avidin agarose beads. 
Finally, the current study analyzed bacteria grown in broth culture, whereas the previous 
study analyzed bacteria grown on plates.  Collectively, these modified approaches were 
helpful in enhancing the detection of outer membrane proteins and reducing 
contamination from cytoplasmic proteins.  To determine whether the bacterial growth 
conditions had a major influence on the results, I conducted experiments in which I 
compared preparations of biotinylated proteins derived from bacteria grown in broth 
culture with preparations of biotinylated proteins derived from bacteria grown on blood 
agar plates. In comparison to preparations of biotinylated proteins from bacterial grown 
in broth, preparations of biotinylated proteins from bacteria grown on solid medium had 
a lower proportion of assigned spectra for annotated OMPs (relative proportion of total 
assigned spectra, plate vs. broth = 0.5) and a higher proportion of assigned spectra for 
annotated intracellular proteins (relative proportion of total assigned spectra, plate vs. 
broth = 9.9) (135). 
The set of proteins meeting three criteria for surface localization (Table 3) 
included three cag pathogenicity island (PAI)-encoded proteins that are components of 
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the cag T4SS (Cag3, CagM and CagT) (33). I also detected surface-exposed proteins 
that were previously annotated as lipoproteins. Among the proteins shown in Table 3, 
five proteins contain a sequence motif known as a lipobox (required for the recognition 
of posttranslational lipidation machinery), based on analysis by DOLOP (7) [HpaA 
paralog HP0492, CagT HP0532, predicted lipoprotein HP1002, Lpp20 (HP1456), and 
predicted lipoprotein HP1571].  In E. coli and many other well-studied Gram negative 
species, most lipoproteins are anchored to either the outer membrane or the inner 
membrane and face the periplasm (91), but some lipoproteins may also be surface-
exposed and exported to the bacterial surface by an unknown mechanism (for example, 
JlpA in C. jejuni and TbpB in N. meningitidis) (13, 75, 95). The findings in the current 
study suggest that the surface of H. pylori is decorated with multiple lipoproteins.  The 
Lol system, which is required for lipoprotein export, is considerably different in H. pylori 
compared to many other bacterial species (77), and this could potentially be a factor 
that influences the localization of H. pylori lipoproteins. Finally, I detected multiple 
surface-exposed that are annotated as “hypothetical proteins”. Further study will be 
required to investigate the localization and functions of these proteins in greater detail.    
Several proteins previously reported to be localized to the surface of H. pylori are 
not included on the list of proteins in Table 3, which indicates that this is not a 
comprehensive list of the proteins exported to the H. pylori surface.  Therefore, I also 
analyzed the proteins that met two criteria consistent with a surface-exposed outer 
membrane localization (Figure 5) (135).  This analysis revealed that the set of proteins 
enriched in the biotinylated preparations and enriched in the total membrane 
preparations (but not enriched in the Triton-insoluble outer membrane preparation) 
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contained numerous proteins that are known or predicted to be localized to the outer 
membrane, such as HopA, HopM, HopN, HopU/BabC, and HorF.    
Although the experiments reported in this manuscript provide a much more 
comprehensive understanding of the H. pylori cell-surface proteome than has been 
previously reported, there are several limitations of the current study.  First, I analyzed 
mainly bacteria that were cultured in a single growth condition (late log phase from broth 
culture). These conditions were selected based on the results of a previous microarray 
gene expression study, which reported that several virulence-associated genes were 
maximally expressed in the late-log phase of growth (130). Additional surface-exposed 
proteins might be detectable if alternate conditions were studied.   Identification of 
surface-exposed proteins under well-defined laboratory conditions, as described in this 
study, provides an important foundation for future studies investigating how the surface 
proteins of H. pylori change under alternate growth conditions. Second, the mass 
spectrometry-based approach used in these studies might fail to detect surface proteins 
that contain a small number of tryptic cleavage sites, surface proteins with extensive 
post-translational modifications, or surface proteins expressed in low abundance. 
Finally, I studied only a single strain, which is known to lack production of at least four 
outer membrane proteins [HopP/SabA, HopO/SabB, HopZ, and HomB] (3, 132) and 
lacks flagella (124).   
Many of the surface-exposed proteins identified in this study are predicted to be 
exported through a process that involves Sec-dependent cleavage of an amino-terminal 
signal sequence. In support of this view, I detected non-tryptic cleavage events near the 
amino-terminus of numerous proteins. The presence in many of these proteins of a 
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conserved C-terminal motif ending in phenylalanine or tyrosine, and containing 
hydrophobic residues at -1, -3, -5, -7, -8, -9 and -15 positions, is consistent with 
insertion of these proteins into the outer membrane through a Bam-dependent process 
(13, 45, 128).  Most of the Hop or Hor proteins contained the consensus C-terminal 
motif [Y/F X R XXX V/F Y XX Y XXX F/Y].   Surprisingly, many of the surface-exposed 
proteins detected in this study, including several putative lipoproteins, did not contain a 
C-terminal motif terminating in phenylalanine or tyrosine, but instead terminated in 
lysine.  The mechanism by which these and other proteins lacking a typical C-terminal 
motif are exported to the bacterial surface is not known.   
As an additional approach for analyzing the cell-surface proteome of H. pylori, I 
subjected intact bacteria to treatment with proteinase K and sought to identify a subset 
of surface-exposed proteins that were susceptible to proteolysis. Initial studies, based 
on analyzing the total numbers of spectral counts assigned to individual proteins, 
allowed us to identify 7 surface-exposed proteins [VacA, BabA, HopQ, BabB, BabC 
(HopU), HomA, and HomD] that were highly susceptible to protease digestion. VacA is 
a toxin that is secreted through an autotransporter pathway (20, 34), and subsequently 
can be released as a soluble protein into the extracellular space or remain attached to 
the bacterial surface (20, 55).  BabA is an H. pylori adhesin that binds to the Lewis b 
antigen on host cells (54), and HopQ is an outer membrane protein that influences the 
activity of the cag type IV secretion system (10).  In contrast to VacA, BabA, and HopQ, 
virtually nothing is known about the functions of BabB, BabC,  HomA and HomD. BabA, 
BabB, BabC and HopQ are all classified as Hop proteins, whereas HomA and HomD 
are classified within a small family of OMPs known as Hom proteins (3). A previous 
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study used proteinase K treatment coupled with 2D gel electrophoretic methods to 
identify five protease-susceptible surface-exposed H. pylori proteins (118).  Two of the 
proteinase K-susceptible proteins identified in the previous study (VacA and HopQ) 
(118) were also shown to be protease-susceptible in the current study.  
I also analyzed the protein coverage of peptides with assigned spectra from the 
proteinase K experiments at the level of individual amino acids, which provided a more 
sensitive approach for detecting proteins that were susceptible to proteolytic cleavage. 
By using this approach, I identified 15 proteins that were protease-susceptible.  All but 
one of these were identified as enriched in at least two out of the three biotinylation and 
cell fractionation experiments (VacA was enriched in TM and OM, HomA and BabC 
were enriched in the biotinylated preparations and the TM fractionations)  (Figure 12).  
Conversely, the majority of surface-exposed proteins identified in the biotinylation and 
cell fractionation experiments were not susceptible to proteolytic cleavage. Thus, the 
proteinase K experiments identified a specialized subset of protease-susceptible 
surface-exposed proteins with properties that differ from those of protease-resistant 
surface-exposed proteins.  
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Figure 12. Subset of surface-exposed outer membrane proteins that are 
susceptible to digestion by proteinase K.  Among the identified using methods based 
on biotinylation or differential detergent solubility (Figure 5 and Table 3), 13 were 
susceptible to digestion by extracellular proteinase K. TM / OM corresponds to proteins 
enriched in either the TM > CP,PP or OM > IM. 
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The set of protease-susceptible proteins included numerous OMPs classified 
within the Hop or Hom family, as well as VacA and a VacA-like protein (FaaA) (Table 6).  
Among the protease-susceptible Hop and Hom proteins, the C-terminal regions were 
resistant to protease digestion, whereas the N-terminal portions were susceptible.  
These data suggest that the N-terminal portions of these OMPs are exported beyond 
the outer membrane. The protease-resistant C-terminal domains of these OMPs are 
predicted to have multiple trans-membrane β-strands consistent with a β-barrel 
structure (based on the use of the program BOCTOPUS), and all contain the conserved 
C-terminal motif shown in Figure 8.  Based on similarities between the protease 
susceptibility patterns of VacA and OMPs, I suggest that the N-terminal domains of 
these OMPs are exported beyond the outer membrane through an autotransporter (type 
V secretion) pathway, similar to the secretion of the VacA passenger domain (20, 34). In 
contrast to VacA, which undergoes proteolysis to cleave the passenger domain from the 
β-barrel domain, there is not yet any evidence that the protease-susceptible OMPs 
undergo similar proteolytic cleavage.  
Although a subset of annotated OMPs were susceptible to proteolytic digestion, 
many others were relatively resistant (Table 7). All three Hom proteins detected in this 
study (HomA, HomC and HomD) and many of the Hop proteins exhibited evidence of 
susceptibility to proteolytic cleavage, whereas Hof and Hor proteins were relatively 
resistant (Table 7).  There are several possible explanations that may account for the 
observed differences in susceptibility to proteolytic cleavage, including variation among 
the proteins in the proportion of β-barrel structure, differences among the proteins in the 
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orientation of large loops (projecting toward the periplasm or the bacterial surface), 
differences in physical accessibility of extracellular domains to the protease active site, 
and differences in amino acid composition.  In contrast to the protease-susceptible Hop 
proteins, at least one of the Hop proteins resistant to proteolytic cleavage (HopE) is 
predicted to have a structure comprised of predominantly transmembrane β-strands, 
based on analysis by BOCTOPUS (Figure 11), which likely accounts for its resistance to 
proteolysis. Similarly, HorB and HofC are predicted to have structures comprised of 
predominantly transmembrane β-strands, and these proteins were resistant to 
proteolysis (Figure 11).  Thus, the current data suggest that β-barrel-containing 
segments of H. pylori OMPs are relatively resistant to proteolysis, whereas large 
extracellular domains of H. pylori OMPs with non-β-barrel structures are often 
susceptible to proteolysis (Figure 13).    
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Figure 13. Proposed model of proteinase K-susceptibility results. The amino-
termial portions of 13 OMPs were highly susceptible to extracellular proteinase K 
digestion. The carboxy-terminal portions of these OMPs were resistant to proteinase K. 
OMP BabA is illustrated as a representative example. Regions of protease-resistance 
corresponded to regions of proteins with many predicted trans-membrane β strands. 
Proteins with predicted trans-membrane β strands occurring throughout the length of 
the amino acid sequence also were protease-resistant. OMP FecA3 is a representative 
example. Also, non-OMPs identified on the surface using biotinylation and fractionation 
were not susceptible to extracellular proteinase-K (exception was VacA-paralog FaaA). I 
speculate these proteins either do not contain large extracellular domains or are 
innately resistant to proteinase K.  
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The passenger domains of most proteins secreted through an autotransporter 
(type V secretion) pathway, including H. pylori VacA, have β-helical structures (42, 63). 
Interestingly, analysis of the protease-sensitive putative autotransporter proteins 
identified in this study using the program BetaWrapPro predicted the existence of β-
helical structure within VacA (consistent with the crystal structure of this protein) (42, 
63), but not within the other protease-sensitive OMPs.  Thus, it seems likely that the N-
terminal portions of many protease-susceptible H. pylori OMPs differ in structure 
compared to most known autotransporter passenger domains. In support of this view, a 
recent X-ray crystallographic study of the N-terminal region of a H. pylori SabA (an OMP 
that is related to BabA, but not produced by the H. pylori strain analyzed in this study) 
revealed primarily α-helical motifs instead of the β-helical motifs characteristic of most 
autotransporter passenger domains (63, 105).   
 In summary, these experiments provide valuable new insights into the repertoire 
of proteins present on the surface of H. pylori. In addition, my detailed analysis of the 
susceptibility of surface proteins to proteinase K digestion provides the first systematic 
analysis of the topology of H. pylori cell-surface proteins, and provides experimental 
evidence in support of an autotransporter mode of export for many of these proteins.  
Several of the surface-exposed proteins identified in this study are known to have 
important roles in mediating H. pylori-host interactions, and the functions of others are 
not yet known. The surface-exposed proteins with large extracellular domains identified 
in this study are especially likely to be localized in close proximity to host cells, and 
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therefore, I suggest that these proteins in particular may have important roles in 
mediating interactions with the host.   
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CHAPTER III 
 
ALTERATION OF THE HELICOBACTER PYLORI MEMBRANE PROTEOME IN 
RESPONSE TO CHANGES IN ENVIRONMENTAL SALT CONCENTRATION 
 
Introduction 
Multiple risk factors for the development of symptomatic gastric disease in H. 
pylori-infected humans have been identified. High dietary salt intake is one such factor, 
and has been identified as a risk factor for gastric cancer (23, 36, 37, 133). Currently, 
the reason for this is unknown. My hypothesis is high levels of environmental salt alter 
the abundance of several surface-exposed H. pylori proteins and may be contributing to 
adverse clinical outcomes. This hypothesis is based on the observation that CagA is 
more abundant in bacteria grown under high salt conditions compared to low salt 
conditions (81, 82). Therefore, it is hypothesized that salt-induced alterations in CagA 
production contribute to the increased gastric cancer risk associated with a high salt diet 
(23, 40). There are likely other proteins that also change in abundance when H. pylori is 
grown under high salt conditions 
Thus far, there has been relatively little progress in analyzing the regulation of H. 
pylori membrane protein production in response to changes in environmental salt 
concentration. A previous study used 2D-DIGE proteomic methods to analyze H. pylori 
lysates and identified 31 H. pylori proteins that are regulated in response to changes in 
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the salt concentration of the bacteriologic culture medium (81), but 2D-DIGE is 
considered suboptimal for detecting and monitoring the abundance of membrane 
proteins and low-abundance proteins (137). Therefore, the previous 2D-DIGE study 
may have failed to detect various salt-responsive changes in the abundance of H. pylori 
membrane proteins.   
   In the current study, I sought to identify H. pylori membrane proteins that 
change in abundance in response to alterations in environmental salt concentrations. I 
used both a label-free spectral counting approach, as well as Isobaric Tags for Relative 
Absolute Quantitation (iTRAQ). I selected the laboratory strain 26695 for analysis since 
it is a prototype strain with a detailed genome annotation, and I also analyzed strain 
7.13, which can colonize Mongolian gerbils and promote the development of gastric 
cancer in this model (38). I report on salt-responsive changes in protein abundance that 
were detected in both H. pylori strains, as well as strain-specific responses. I discuss 
how the observed changes in the bacteria in response to high salt conditions may 
influence interactions between H. pylori and gastric epithelial cells, as well as the host 
immune response to the bacteria, and propose that these changes may account, at 
least in part, for the increased risk of gastric cancer associated with a high salt diet. 
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Methods 
Bacterial strains and growth conditions 
 H. pylori strain 26695 is a reference strain with a fully annotated genome 
sequence that was originally isolated from a patient that had gastritis (28, 132).  H. 
pylori strain 7.13 can colonize the stomach in a Mongolian gerbil model, sometimes 
resulting in gastric cancer (40, 96). The complete genome sequence of a closely related 
strain (strain B8) was used in the current study when analyzing proteomic data (32). 
Both strains have a functional cag T4SS.  Strain 26695 lacks flagella and does not 
produce several OMPs (including HopZ, SabA, SabB, and HomB) (132). Strain 7.13 
does not produce VacA (32, 92). For the proteomic studies, H. pylori strains were grown 
at 37°C in ambient air containing 5% CO2 on either trypticase soy agar plates 
supplemented with 5% sheep blood, or in sulfite-free Brucella broth supplemented with 
10% fetal bovine serum (BB-FBS) and containing varying concentrations of added 
sodium chloride: 0.25% (low salt), 0.5% (regular salt), or 1.1% (high salt) (81). All 
proteomic analyses of the effect of salt concentration on protein abundance were 
performed by comparing bacteria grown in low salt conditions (0.25% added sodium 
chloride) with bacteria grown in high salt conditions (1.1% added sodium chloride). 
Bacteria were grown in the presence of 0.5% added sodium chloride for purposes of 
generating an unlabeled control preparation, as part of biotinylation experiments. The 
salt concentrations used in these experiments do not cause substantial alterations in 
bacterial growth (82). 
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Sample preparation for proteomic analysis 
 Bacteria were grown until late-log phase (absorbance 600 nm of approximately 
0.7) as described previously (135). Bacteria were pelleted at 3,500 x g and 
resuspended in TNKCM (50 mM Tris, pH 7.4, 100 mM NaCl, 27 mM KCl, 1 mM CaCl2, 
0.5 mM MgCl2). Bacteria were pelleted again and resuspended in lysis buffer (50 mM 
Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, protease inhibitor cocktail). Lysates were 
generated via sonication (4 pulses on ice at 15 sec each, with 45 sec rest between 
pulses). Unbroken cells were pelleted at 4,500 x g for 10 min. Total membrane fractions 
were generated by ultracentrifugation of the lysates at 40,000 x g for 30 min. Previous 
studies have shown that these total membrane fractions are enriched in inner and outer 
membrane proteins, but also contain detectable cytoplasmic and periplasmic proteins 
(119, 135). Total membrane pellets were rinsed with lysis buffer and solubilized in RIPA 
buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium 
deoxycholate, protease inhibitor cocktail). Non-solubilized debris was removed by 
centrifugation at 21,000 x g for 10 min. Total protein concentration was determined with 
BCA reagents (Pierce).  
Biotinylation of surface-exposed proteins 
 Bacteria were grown to late-log phase in medium containing either 0.25% NaCl 
(low salt) or 1.1% NaCl (high salt), and surface-exposed proteins on intact bacteria were 
biotinylated and purified as described in Chapter II. To generate an unlabeled control 
preparation, bacteria were grown in medium containing 0.5% NaCl (normal salt), and 
the non-biotinylated bacteria were processed in parallel with the biotinylated bacteria. 
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This biotinylation protocol allowed labeling of proteins on the surface of strain 26695, 
but similar experiments with strain 7.13 were less successful, possibly due to fragility of 
the latter strain during the multiple steps required for biotinylation.      
Label-free analysis 
 For each strain analyzed, one culture was grown in high salt medium (1.1% 
NaCl) and one culture was grown in low salt medium (0.25% NaCl). Proteins in the 
membrane preparations were precipitated with ice-cold acetone overnight at -20°C. 
Following precipitation, samples were centrifuged at 18,000 x g at 4°C, and precipitates 
were washed with cold acetone, dried, and reconstituted in 8M urea in 250 mM Triethyl 
ammonium bicarbonate (TEAB) (pH 8.0). Samples were reduced with Tris(2-
carboxyethyl)phosphine (TCEP), alkylated with methyl methanethiosulfonate (MMTS), 
diluted with TEAB to obtain a solution containing 2M urea, and digested with 
sequencing-grade trypsin overnight at 37°C. For label-free 2D-LC-MS experiments, 
peptides were loaded onto a self-packed biphasic C18/SCX MudPIT column using a 
helium-pressurized cell (pressure bomb). The MudPIT column consisted of 360 x 150 
m i.d. fused silica, which was fritted with a filter-end fitting (IDEX Health & Science) 
and packed with 6 cm of Luna SCX material (5 m, 100Å) followed by 4 cm of Jupiter 
C18 material (5 m, 300Å, Phenomenex).  Once the sample was loaded, the MudPIT 
column was connected using an M-520 microfilter union (IDEX Health & Science) to an 
analytical column (360 m x 100 m i.d.), equipped with a laser-pulled emitter tip and 
packed with 20cm of C18 reverse phase material (Jupiter, 3m beads, 300Å, 
Phenomenex).  Using an Eksigent NanoLC HPLC and Autosampler, MudPIT analysis 
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was performed with an 11-step salt pulse gradient (25, 50, 75, 100, 150, 200, 250, 300, 
500, 750 mM, 1M ammonium acetate). Following each salt pulse, peptides were 
gradient-eluted from the reverse phase analytical column at a flow rate of 500 nL/min, 
and the mobile phase solvents consisted of 0.1% formic acid, 99.9% water (solvent A) 
and 0.1% formic acid, 99.9% acetonitrile (solvent B). For the peptides from the first 10 
SCX fractions, the reverse phase gradient consisted of 2–40 %B in 90 min, followed by 
a 15 minute equilibration at 2 %B. For the last SCX-eluted peptide fractions, the 
peptides were eluted from the reverse phase analytical column using a gradient of 2-98 
%B in 100 min, followed by a 10 min equilibration at 2 %B. Peptides were introduced via 
nano-electrospray into an LTQ-Orbitrap Velos  mass spectrometer (Thermo Scientific), 
and the data were collected using a 17-scan event data-dependent method. Full scan 
(m/z 350-2000) spectra were acquired with the Orbitrap as the mass analyzer 
(resolution 60,000), and the 16 most abundant ions in each MS scan were selected for 
collision-induced dissociation in the LTQ.  An isolation width of 2 m/z, activation time of 
10 ms, and 35% normalized collision energy were used to generate MS/MS spectra.  
The MSn AGC target value was set to 1 x 104, and the maximum injection time was set 
to 100 ms. Dynamic exclusion was enabled, using a repeat count of 1 within 10 sec and 
exclusion duration of 30 sec.  For peptide identifications, tandem mass spectra were 
converted into DTA files using Scansifter and were searched using a custom version of 
Sequest (Thermo Fisher Scientific) operating on the Vanderbilt ACCRE computing 
cluster (85). MS/MS spectra were searched against a concatenated forward and 
reverse (decoy) database containing the H. pylori 26695 or B8 strain subsets of 
UniprotKB protein database (www.uniprot.org). Additional search parameters included: 
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trypsin enzyme specificity, monoisotopic masses used for searching product ions, and 
allowance of oxidation of methionine and MMTS modification of cysteine as variable 
modifications. Scaffold 4.1.1 (Proteome Software) was used to summarize and compare 
search results, where a minimum probability threshold of 95% was required for peptide 
identifications and data were filtered to a false-discovery rate (FDR) of <3% at the 
protein level.   
To analyze preparations from biotinylated bacteria, shotgun proteomic analysis 
was performed by first resolving 50 g of protein preparations approximately 1 cm using 
a 10% Novex precast gel, and then performing in-gel tryptic digestion at 37oC to recover 
peptides (125).  These peptides were analyzed via MudPIT essentially as described in 
(86, 90) and above, with the exception that data were acquired using an LTQ mass 
spectrometer (Thermo Scientific) and MudPIT separations performed using a 
NanoAquity HPLC system (Waters).  Unlike the analysis of total membrane 
preparations, where data were collected over 11 salt steps, only 8 steps (~ 16 hr) were 
utilized for analyzing this less complicated cell surface proteome. Both the intact 
masses (MS) and 5 data-dependent fragmentation (MS/MS) spectra of the peptides 
were collected. The peptide MS/MS spectral data were searched against the H. pylori 
26695 protein databases using Sequest  (141). Resulting identifications were collated 
and filtered using IDPicker 3 (84), where a minimum probability threshold of 95% was 
required for peptide identifications and data were filtered to a false-discovery rate (FDR) 
of <3% at the protein level. When analyzing data from biotinylated preparations, only 
spectra assigned to unique proteins were considered for spectral counting. 
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iTRAQ analysis 
 One 2-plex iTRAQ experiment was conducted for each H. pylori strain assayed. 
Total membrane preparations were generated as described above, and proteins were 
precipitated with ice-cold acetone overnight at -20°C. Following precipitation, samples 
were centrifuged at 18,000 x g at 4°C, and precipitates were washed with cold acetone, 
dried, and reconstituted in 8M urea in 250 mM TEAB (pH 8.0). Samples were reduced 
with 5 uL of 50 mM TCEP, alkylated with 2.5uL of 200 mM MMTS, diluted 4-fold with 
TEAB to obtain a final solution containing 2M urea, and digested with sequencing-grade 
trypsin overnight.  Peptides were then labeled with iTRAQ reagents according to the 
manufacturer’s instructions (reporter tags: strain 26695, low salt = 114, high salt = 117; 
strain 7.13, low salt = 115, high salt = 117) (AB Sciex). For 50 ug of protein, 1 unit of 
labeling reagent was used. Labeling reagent was reconstituted in ethanol such that 
each protein sample was labeled at a final concentration of 90% ethanol, and labeling 
was performed for 2 hr. The resulting labeled peptides were then desalted by a modified 
Stage-tip method (116). iTRAQ-labeled samples were mixed and acidified with TFA. A 
disc of C18 extraction membrane (Chrom Tech. Inc. C18 SPE Empore disk) was cored 
with a 16-gauge needle, and the cored piece of membrane was fitted tightly into a 200 
l pipet tip. Three milligrams of C18 resin (Phenomenex Jupiter C18, 5 m particle size) 
was suspended in 200 l of methanol and loaded into the pipet tip containing the cored 
C18 membrane. The C18 material was packed into the tip using centrifugation to form a 
resin-packed C18 clean-up tip (resin tip).  Multiple resin tips were used for desalting the 
mixed 2-plex iTRAQ samples. Resin tips were equilibrated with 0.1% TFA in HPLC-
grade water, labeled peptides were loaded into the tip by centrifugation, washed with 
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0.1% TFA, and eluted with 100 l of 80% ACN containing 0.1%TFA. All eluted peptides 
were pooled together and dried by speed-vac centrifugation. Peptides were 
reconstituted in 0.1% formic acid, and peptides were loaded onto a self-packed biphasic 
C18/SCX MudPIT column using a helium-pressurized cell (pressure bomb). The 
MudPIT column consisted of 360 x 150 m i.d. fused silica, which was fritted with a 
filter-end fitting (IDEX Health & Science) and packed with 6 cm of Luna SCX material (5 
m, 100Å) followed by 4 cm of Jupiter C18 material (5 m, 300Å, Phenomenex).  Once 
the sample was loaded, the MudPIT column was connected using an M-520 microfilter 
union (IDEX Health & Science) to an analytical column (360 m x 100 m i.d.), 
equipped with a laser-pulled emitter tip and packed with 20 cm of C18 reverse phase 
material (Jupiter, 3 m beads, 300Å, Phenomenex).  Using an Eksigent NanoLC HPLC 
and Autosampler, MudPIT analysis was performed with a 13-step salt pulse gradient (0, 
25, 50, 75, 100, 150, 200, 250, 300, 500, 750 mM, 1M, and 2M ammonium acetate). 
Following each salt pulse, peptides were gradient-eluted from the reverse analytical 
column at a flow rate of 500 nL/min, and the mobile phase solvents consisted of 0.1% 
formic acid, 99.9% water (solvent A) and 0.1% formic acid, 99.9% acetonitrile (solvent 
B). For the peptides from the first 11 SCX fractions, the reverse phase gradient 
consisted of 2–50 %B in 90 min, followed by a 15 min equilibration at 2 %B. For the last 
2 SCX-eluted peptide fractions, the peptides were eluted from the reverse phase 
analytical column using a gradient of 2-98 %B in 100 min, followed by a 10 min 
equilibration at 2 %B. Peptides were introduced via nano-electrospray into a Q Exactive 
mass spectrometer (Thermo Scientific). The Q Exactive was operated in the data-
dependent mode acquiring HCD MS/MS scans (R = 17,500) after each MS1 scan (R = 
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70,000) on the 18 most abundant ions using an MS1 ion target of 1 × 106 ions and an 
MS2 target of 5 × 104 ions. The maximum ion time for MS/MS scans was set to 100 ms, 
the HCD-normalized collision energy was set to 26, dynamic exclusion was set to 25 
sec, and peptide match and isotope exclusion were enabled.  Mass spectra were 
processed using the Spectrum Mill software package (version B.04.00) (Agilent 
Technologies). MS/MS spectra acquired on the same precursor m/z (± 0.01 m/z) within 
± 1 sec in retention were merged. MS/MS spectra of poor quality which failed the quality 
filter by not having a sequence tag length >1 were excluded from searching. A minimum 
matched peak intensity requirement was set to 50%. For peptide identification, MS/MS 
spectra were searched against either the H. pylori strain 26695 or strain B8 subsets of 
the UniprotKB protein database (www.uniprot.org). Additional search parameters 
included: trypsin enzyme specificity with a maximum of three missed cleavages, ± 20 
ppm precursor mass tolerance, ± 20 ppm (HCD) product mass tolerance, and fixed 
modifications including MMTS alkylation of cysteines and iTRAQ labeling of lysines and 
peptide N-termini. Oxidation of methionine was allowed as a variable modification. 
Autovalidation was performed such that peptide assignments to mass spectra were 
designated as valid following an automated procedure during which score thresholds 
were optimized separately for each precursor charge state and the maximum target-
decoy-based false-discovery rate (FDR) was set to 1.0%.  To obtain iTRAQ protein 
ratios, the median was calculated for all peptides assigned to each protein. Because of 
a high interrelatedness among H. pylori outer membrane proteins (OMPs), only 
peptides that could be assigned to a single OMP were considered when calculating 
iTRAQ protein ratios. 
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Statistical analysis of assigned spectra 
 For label-free analysis of total membrane preparations, the identification of 
proteins enriched in one preparation compared to another was based on two criteria. 
First, the relative abundance of assigned spectra was calculated using a normalized 
ratio of spectral counts (Rsc): log2 (
𝑎+0.5
𝑏+0.5
) + log2 (
𝑏𝑡𝑜𝑡𝑎𝑙−𝑏+0.5
𝑎𝑡𝑜𝑡𝑎𝑙−𝑎+0.5
) (101). For the identification 
of salt-responsive proteins, “a” indicates high salt and “b” indicates low salt. For the 
biotinylation experiment to identify biotinylated proteins, “a” indicates the biotinylated 
preparation and “b” indicates the unlabeled control. As a second criteria, the 
significance of differences in numbers of assigned spectra was calculated using a 
Fisher’s exact test (FET) with Benjamini-Hochberg (BH) multiple test correction. Rsc 
values were normalized to mean of zero prior to analysis.  Proteins designated as salt-
responsive had a normalized Rsc of < -0.585 or >0.585 (corresponding to a >1.5 fold 
change), and a FET BH p value < 0.05.  
 Triplicate samples of biotinylated preparations were analyzed and the resulting 
assigned spectra were merged prior to analysis (135). Proteins in biotinylated samples 
were identified as enriched over the mock control preparation (no biotinylation) with a 
FET BH p value < 0.05 and Rsc > 1 (135). Salt-responsive proteins were identified as 
described above for the label-free analysis. 
To analyze iTRAQ data, frequency distribution histograms for log2 protein ratios 
were generated using Graphpad Prism 5.0. Ratios were binned to a value of 0.1. Log2 
ratios were then fitted to a normal distribution using least squares (non-linear) 
regression. The mean derived from the Gaussian fit was used to normalize Log2 ratios 
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for a bin center of zero. The mean and standard deviation derived from the Gaussian fit 
were used to generate a Z-score for each Log2 ratio and calculate p values that were 
subsequently corrected for multiple comparisons by the BH method (129). Proteins with 
a p < 0.05 were defined as significantly different in abundance. For strains 26695 and 
7.13, p values of 0.05 correspond approximately to absolute Log2 ratios of 1 and 0.8, 
respectively. 
 Non-linear regression analyses were performed in Graphpad Prism (Figure 14).  
Z-score, Fisher’s exact test, Student’s t-test, and multiple test corrections were 
calculated in R (http://www.R-project.org).   
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Figure 14. Distribution of Rsc or iTRAQ log2 ratios (protein abundance in bacteria 
from high salt conditions compared to bacteria from low salt conditions). A) 
26695 label-free analysis (n = 826), B) 7.13 label-free analysis (n= 1,091), C) 26695 
iTRAQ (n = 849), D) 7.13 iTRAQ (n = 1,178). and E) biotinylated preparations (n = 643). 
Curves were generated by non-linear regression analysis of Rsc spectral counting ratios 
or iTRAQ log2 ratios, and the data were grouped with bin values of 0.1. 
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H. pylori motility assay 
 H. pylori motility was analyzed as described previously (114).  Briefly, overnight 
broth cultures of H. pylori 7.13 were back-diluted to an optical density at 600 nm of 
0.1.  1-µl aliquots of the bacterial suspensions were then stabbed into Brucella soft agar 
plates containing 5% FBS, 0.35% agar, and varying concentrations of sodium 
chloride. Diameters of bacterial halos were measured following a 5 day incubation of the 
plates at 37°C in a microaerobic atmosphere generated by GasPak EZ Campy packs 
(BD). At least 12 replicates were assayed for each condition. 
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Results 
Salt-responsive proteins in strain 26695 identified by label-free and iTRAQ analyses 
 As an initial approach for identifying H. pylori proteins that differ in abundance 
depending on the sodium chloride concentration of the culture medium, I conducted 
experiments with the well-characterized H. pylori reference strain 26695.  I cultured 
strain 26695 in either low-salt medium or high-salt medium, and generated subcellular 
fractions enriched in bacterial membrane proteins.  I then analyzed the preparations by 
label-free MudPIT. Among 806 H. pylori proteins identified in the preparations, there 
was a significant difference in the number of assigned spectra for 66 proteins when 
comparing preparations from bacteria grown under low-salt and high-salt conditions 
(136). Thirty-eight proteins were more abundant in preparations from bacteria grown in 
low salt conditions, and twenty-eight proteins were more abundant in preparations from 
bacteria grown in high salt conditions (136).  
As another approach to identify salt-responsive proteins, I used iTRAQ methods 
to analyze the membrane preparations from strain 26695, grown under high and low 
salt conditions, and identified 849 H. pylori proteins in the preparations. By using Z-
score statistical analysis, I identified 22 of these proteins that were significantly different 
in abundance depending on the salt concentration (Table 8). Nine proteins were more 
abundant in bacteria grown under low salt conditions. These included the vacuolating 
toxin VacA, a VacA-like protein (FaaA), an outer membrane protein (FecA3) and 
multiple hypothetical proteins. Two proteins identified in this analysis (LysA and a 
hypothetical protein) are encoded by adjacent genes (HP0290 and HP0291) that are 
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predicted to be members of an operon.  Thirteen proteins were more abundant in 
bacteria grown under high salt conditions (Table 8). These included CagA, flagellar 
hook protein FlgE2 (HP0908), a fibronectin domain containing protein (HP0746), an 
amidase (AmiE), a sodium and chloride-dependent transporter (HP0497), a conserved 
hypothetical secreted protein (HP1464), and multiple other hypothetical proteins. A 
protein product of HP0964, previously annotated as a pseudogene, was also identified 
as more abundant in bacteria grown under high salt conditions (Table 8).  
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Table 8: Salt-responsive proteins in strain 26695 identified by iTRAQ analysis  
Proteins more abundant in low salt compared to high salt 
Accession Uniprot KEGG 
Fold 
Difference 
Description 
HP1400*
# 
O25950 Transport 2.53 iron(III) dicitrate transport protein (FecA3) 
HP0664*
& 
K4NED0 NA 2.36 hypothetical protein 
HP0887* P55981 Pathogenesis 2.36 vacuolating cytotoxin 
HP0802 O08315 
riboflavin biosynthetic 
process 
2.33 GTP cyclohydrolase II (RibA) 
HP0290* P56129 lysine biosynthetic process 2.30 
diaminopimelate decarboxylase (dap decarboxylase) 
(LysA) 
HP1532 O26060 glutamine metabolic process 2.27 
glucosamine fructose-6-phosphate aminotransferase 
(isomerizing) (GlmS) 
HP0721 O25423 NA 2.08 hypothetical protein 
HP0291 O25064 
chorismate metabolic 
process 
2.02 hypothetical protein 
HP0610*
# 
O25331 NA 2.01 toxin-like outer membrane protein (FaaA) 
 
Proteins more abundant in high salt compared to low salt 
Accession Uniprot KEGG 
Fold 
Difference 
Description 
HP0964* O25617 NA 3.86 hypothetical protein 
HP0574 O25298 pentose-phosphate shunt 3.38 ribose 5-phosphate isomerase B (RpiB) 
HP0547* P55980 toxin transport 3.16 cag pathogenicity island protein (CagA) 
HP1584 P55996 proteolysis 3.15 sialoglycoprotease (Gcp) 
HP1248 P56123 
nucleic acid phosphodiester 
bond hydrolysis 
2.92 virulence associated protein homolog (VacB) 
HP0294* O25067 
nitrogen compound 
metabolic process 
2.76 aliphatic amidase (AmiE) 
HP1464* O26000 NA 2.58 conserved hypothetical secreted protein 
HP0908
! 
O25566 NA 2.37 flagellar hook (FlgE2) 
HP0497 O25239 transmembrane transport 2.37 sodium- and chloride-dependent transporter 
HP1588*
& 
O26107 NA 2.32 conserved hypothetical protein 
HP0337 O25104 NA 2.23 hypothetical protein 
HP1124 O25749 NA 2.13 hypothetical protein 
HP0746*
# 
O25442 NA 1.97 fibronectin domain-containing protein 
 
* Also significant in label-free analysis 
# Also significant in biotinyation experiments 
& Significant in iTRAQ and label-free analyses of strain 26695, but not significant in 
either analysis of strain 7.13 
! Strain 26695 produces two distinct FlgE proteins, FlgE1 (HP0870) and FlgE2 
(HP0908). 
NA: not assigned 
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Eleven (50%) of the 22 proteins identified as salt responsive in the iTRAQ 
experiment were also identified as salt responsive in the label-free MudPIT experiment 
(Table 8 and Figure 15A). Six of the eleven proteins were more abundant in bacteria 
grown under high salt conditions -- CagA, AmiE, fibronectin-domain containing protein 
(HP0476), a product of the annotated pseudogene HP0964, and two hypothetical 
proteins (HP1464 and HP1588). Five of the eleven proteins were more abundant in 
bacteria grown under low salt conditions -- LysA (HP0290), FaaA, HP0664 (hypothetical 
protein), VacA, and FecA3. 
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Figure 15. Identification of salt-responsive proteins by multiple methods.  Venn 
diagrams showing: A) salt-responsive proteins in strain 26695 detected by label free 
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methods compared to iTRAQ methods, B) salt-responsive proteins in strain 7.13 
detected by label-free methods compared to iTRAQ methods, C) the numbers of salt-
responsive proteins identified by iTRAQ analysis of the indicated strains. “26695 and/or 
7.13 label-free” indicates salt-responsive proteins identified by label-free analysis of at 
least one strain. D) Salt-responsive proteins identified by label-free analysis of the 
indicated strains. “26695 and/or 7.13 iTRAQ” indicates salt-responsive proteins 
identified by iTRAQ analysis of at least one strain.  E) Salt-responsive proteins in strain 
26695 identified by the three indicated methods. 
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As another approach to compare the results obtained by the label-free and 
iTRAQ methods, I analyzed the 66 salt-responsive proteins identified in the label-free 
experiments, and evaluated if the directionality of changes in protein abundance 
detected in the label-free experiments matched the directionality of changes in protein 
abundance detected in the iTRAQ experiments (Figure 16A, 16B). In the label-free 
experiments, 28 proteins were upregulated under high salt conditions and 38 were 
upregulated under low salt conditions. Similar salt-induced changes were observed in 
the iTRAQ experiments (p<0.001, Student’s t-test, Figure 16B).  The same patterns 
were observed even when excluding the proteins that were identified by Z-score 
analysis of the iTRAQ data (Table 8, Figure 16B). These findings illustrate that the two 
different methods yielded similar patterns of results, and suggest that the changes in 
protein abundance were not limited to the relatively small set of salt-responsive proteins 
identified in the statistical analysis of the iTRAQ data.  
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Figure 16. Comparison of iTRAQ results with label-free spectral counting results. 
A) Venn diagrams illustrating the number of salt-responsive proteins identified in strain 
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26695 or strain 7.13 by label-free and iTRAQ methodologies.  B) iTRAQ log2 ratios 
(mean + SD) for multiple sets of proteins from strain 26695, corresponding to different 
segments of the Venn diagram in panel A. C) iTRAQ log2 ratios for multiple sets of 
proteins from strain 7.13, corresponding to different segments of the Venn diagram in 
panel A.  The y-axis shows mean values for the indicated proteins (abundance in high 
salt conditions compared to low salt conditions), based on results of the iTRAQ 
experiments.  iTRAQ+/LF+ indicates salt-responsive proteins identified by both iTRAQ 
and label-free approaches. “All LF” indicates all salt-responsive proteins identified by 
label-free methods, without considering whether or not they were identified by iTRAQ.  
iTRAQ-/LF+ indicates salt-responsive proteins identified by label-free methods but not 
iTRAQ. “High” indicates the group of proteins that exhibited increased abundance under 
high salt conditions compared to low salt conditions in the label-free experiments, and 
“low” indicates the group of proteins that exhibited decreased abundance under high 
salt conditions compared to low salt conditions in the label-free experiments. 
iTRAQ+/LF- indicates a control group (salt-responsive proteins identified by iTRAQ but 
not label-free methods); in this case, “high” and “low” correspond to categories based 
on the iTRAQ data.  ****, Student’s t-test p< 0.001. LF, Label-free. 
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Salt-responsive proteins in strain 7.13 identified by label-free and iTRAQ analyses 
 I next investigated the effects of changes in environmental salt concentration on 
protein abundance in H. pylori strain 7.13. In contrast to strain 26695, which lacks 
flagella and fails to colonize animal models, strain 7.13 produces flagella and can 
promote the development of gastric cancer in a Mongolian gerbil model (40, 96).  I 
cultured strain 7.13 in either low-salt medium or high-salt medium, prepared membrane 
fractions from the bacteria and analyzed the preparations by label-free MudPIT.  A total 
of 1054 H. pylori proteins were identified in these preparations, and 222 of these 
proteins differed in abundance, depending on the salt concentration of the medium 
(136). Among the 222 proteins, 111 were more abundant in bacteria grown under low 
salt conditions, and 111 other proteins were more abundant in bacteria grown under 
high salt conditions (136).  Next I analyzed membrane preparations of strain 7.13 grown 
under high and low salt conditions using iTRAQ. Among 1185 H. pylori proteins 
detected, I identified 56 proteins that were significantly different in abundance (Table 9).  
Nineteen proteins were more abundant in bacteria grown under low salt conditions 
(Table 9). These included two flagellar proteins (FlgE and FlaG), an iron (III) dicitrate 
transport protein (FecA3), and two subunits of quinone-reactive Ni-Fe hydrogenase. 
Thirty nine proteins were more abundant in bacteria grown under high salt conditions 
(Table 9). These included CagA, CagT, a metalloprotease (HP0506), and several outer 
membrane proteins (HorK, HopA, and HopD). 
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Table 9: Salt-responsive proteins in strain 7.13 identified by iTRAQ analysis 
 
Proteins more abundant in low salt compared to high salt 
Accession Uniprot KEGG 
Fold 
difference 
Description 
26695 Homolog 
Locus Tag 
HPB8_1702* D7FGF2 Transport 2.45 
Putative iron(III) dicitrate transport protein 
(FecA3) 
HP1400 
HPB8_1645 D7FG95 
metabolic 
process 
2.43 
Membrane-bound lytic murein 
transglycosylase D 
HP1572 
HPB8_831 D7FDY1 
oxidation-
reduction 
process 
2.32 
Quinone-reactive Ni/Fe hydrogenase, 
small subunit (HydA) 
HP0631 
HPB8_1116 D7FER6 NA 2.26 Putative uncharacterized protein HP0467 
HPB8_258*
&
 D7FCA8 heme binding 2.18 Cytochrome c553 HP1227 
HPB8_625 D7FDC5 
cellular 
aromatic 
compound 
metabolic 
process 
2.15 4-oxalocrotonate tautomerase (DmpI) HP0924 
HPB8_829* D7FDX9 NA 2.1 Modulator of drug activity B (MDA66) HP0630 
HPB8_958*
&
 D7FEA8 NA 2.07 Flagellar protein FlaG HP0751 
HPB8_844* D7FDZ4 
oxidation-
reduction 
process 
2.05 NAD(P)H-flavin oxidoreductase HP0642 
HPB8_822 D7FDX2 
cell wall 
organization 
2.02 UDP-N-acetylmuramate--L-alanine ligase HP0623 
HPB8_188 D7FC38 NA 2.00 Putative uncharacterized protein NA 
HPB8_832*
&
 D7FDY2 
oxidation-
reduction 
process 
1.98 
Quinone-reactive Ni/Fe hydrogenase, 
large subunit (HydB) 
HP0632 
HPB8_176*
&
 D7FC26 translation 1.87 50S ribosomal protein L18 HP1303 
HPB8_153 D7FC03 NA 1.83 Putative uncharacterized protein HP1326 
HPB8_610 D7FDB0 NA 1.83 Putative uncharacterized protein HP0938 
HPB8_1264*
&
 D7FF65 
transmembrane 
transport 
1.8 
Dipeptide ABC transporter, periplasmic 
dipeptide-binding protein (DppA) 
HP0298 
HPB8_195 D7FC45 NA 1.78 Putative uncharacterized protein HP1286 
HPB8_1079*
!
 D7FEM9 
bacterial-type 
flagellum-
dependent cell 
motility 
1.77 Flagellar hook protein FlgE3 HP0870 
HPB8_2* D7FBK2 NA 1.76 Putative uncharacterized protein HP1527 
  
Proteins more abundant in high salt compared to low salt 
Accession Uniprot KEGG 
Fold 
difference 
Description 
26695 Homolog 
Locus Tag 
HPB8_475*
&
 D7FCX5# NA 3.47 Putative uncharacterized protein HP0423|HP1412 
HPB8_1569 D7FG19# NA 3.47 Putative uncharacterized protein NA 
HPB8_1195* D7FEZ5 NA 3.07 Putative uncharacterized protein HP1076 
HPB8_524 D7FD24% NA 2.56 Putative uncharacterized protein NA 
HPB8_555 D7FD55% NA 2.56 Putative uncharacterized protein HP1405 
HPB8_1336*
&
 D7FFD6 NA 2.53 Outer membrane protein HopA HP0229 
HPB8_1699 D7FGE9 NA 2.53 Putative uncharacterized protein HP1397 
HPB8_957*
&
 D7FEA7 NA 2.48 Putative uncharacterized protein HP0750 
HPB8_1043 D7FEJ3 NA 2.43 Putative uncharacterized protein HP0833 
HPB8_385* D7FCN5 NA 2.4 cysteine-rich protein X HcpX HP1117 
HPB8_513* D7FD13 NA 2.23 Putative uncharacterized protein NA 
HPB8_877* D7FE27 NA 2.21 Putative uncharacterized protein HP0674 
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HPB8_p0002 D7GAX3 NA 2.2 Putative uncharacterized protein NA 
HPB8_641* D7FDE1 
DNA duplex 
unwinding 
2.17 
Rep helicase, single-stranded DNA-
dependent ATPase (Rep) 
HP0911 
HPB8_1582 D7FG32 
polysaccharide 
metabolic 
process 
2.17 
Mannose-1-phosphate 
guanylyltransferase 
HP0043 
HPB8_622 D7FDC2 proteolysis 2.16 Protease HtpX homolog HP0927 
HPB8_1057* D7FEK7 
DNA 
modification 
2.15 Type I restriction enzyme, S subunit HP0790 
HPB8_1600*
&
 D7FG51 NA 2.12 Outer membrane protein HopD HP0025 
HPB8_872 D7FE22 
metabolic 
process 
2.04 NAD-dependent deacetylase NA 
HPB8_28 D7FBM8 NA 1.99 Outer membrane protein HorK HP1501 
HPB8_711* D7FDL1 NA 1.98 Cag pathogenicity island protein T HP0532 
HPB8_690 D7FDJ0 
metabolic 
process 
1.97 Uncharacterized metalloprotease yebA HP0506 
HPB8_89 D7FBT9 translation 1.95 50S ribosomal protein L34 HP1447 
HPB8_741* D7FDP1 toxin transport 1.92 Cytotoxin-associated protein A HP0547 
HPB8_998 D7FEE8 
DNA 
modification 
1.89 Type I restriction enzyme, S subunit HP0790 
HPB8_1204 D7FF04 NA 1.87 Putative uncharacterized protein HP1085 
HPB8_794* D7FDU4 NA 1.84 Putative uncharacterized protein HP0596 
HPB8_1567*
&
 D7FG17 NA 1.82 Putative uncharacterized protein HP1411|HP0424 
HPB8_865 D7FE15 
mRNA 
processing 
1.8 Ribonuclease 3 HP0662 
HPB8_537 D7FD37 
DNA 
topological 
change 
1.79 DNA topoisomerase I HP0440 
HPB8_897 D7FE47 
metabolic 
process 
1.79 Acetone carboxylase, alpha subunit HP0696 
HPB8_953* D7FEA3 NA 1.79 Putative uncharacterized protein HP0746 
HPB8_1547*
&
 D7FFZ7 NA 1.79 Putative uncharacterized protein comL HP1378 
HPB8_319* D7FCG9 NA 1.78 Outer membrane protein HopQ HP1177 
HPB8_729 D7FDN0 NA 1.78 Putative uncharacterized protein HP0513 
HPB8_1047* D7FEJ7 NA 1.78 Putative uncharacterized protein HP0836|HP0837 
HPB8_972* D7FEC2 NA 1.77 Putative uncharacterized protein HP0764 
HPB8_24 D7FBM4 
oxidation-
reduction 
process 
1.75 Riboflavin biosynthesis protein (RibG) HP1505 
HPB8_375* D7FCM5 
cell outer 
membrane 
1.75 Peptidoglycan-associated lipoprotein HP1125 
* Also significant in label-free analysis 
& Significant in iTRAQ and label-free analyses of strain 7.13, but not significant in 
either analysis of strain 26695 
! Strain 7.13 produces two distinct FlgE proteins, FlgE1 and FlgE3. 
NA: not assigned 
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Among the 56 proteins produced by strain 7.13 that were identified as 
differentially abundant in iTRAQ experiments, 30 (54%) were identified as differentially 
abundance by both iTRAQ and label-free MudPIT (Table 9 and Figure 15B). Among 
these 30 proteins, 10 were enriched in bacteria grown under low salt conditions; these 
included the outer membrane protein FecA3 and flagellar hook protein FlgE3. The set of 
20 proteins enriched in bacteria grown under high salt conditions included CagA, HopQ, 
CagT, HopD, HopA, and ComL. 
I analyzed the 222 salt-responsive proteins from strain 7.13 that were identified in 
the label-free experiments, and evaluated if the directionality of changes in protein 
abundance detected in the label-free experiments matched the directionality of changes 
in protein abundance detected in the iTRAQ experiments (Figure 16A, 16C).  In the 
label-free experiments, 111 proteins were upregulated under high salt conditions and 
111 were upregulated under low salt conditions. Similar salt-induced changes were 
observed in the iTRAQ experiments (p<0.001, Student’s t-test, Figure 16C).  The same 
patterns were observed even when excluding the proteins that were identified by Z-
score analysis of the iTRAQ data (Table 9, Figure 16C). Thus, similar to the conclusions 
reached in studies of strain 26695, this analysis of the 7.13 data indicates that the two 
methodologic approaches yielded similar patterns of results, and suggest that the 
changes in protein abundance were not limited to the relatively small set of salt-
responsive proteins identified in the statistical analysis of the iTRAQ data.  
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Salt-responsive proteins identified in both strains 26695 and 7.13 
 The analysis of two different H. pylori strains in the experiments described above 
provided us with an opportunity to detect salt-responsive changes in protein abundance 
conserved in multiple strains.  I identified 22 proteins that were salt-responsive in both 
strain 26695 and 7.13, based on a label-free spectral-counting approach (136). By using 
iTRAQ, I identified 3 proteins that were salt-responsive in both strains (CagA, FecA3, 
and fibronectin domain protein) (Figure 15C) (136).  Among the 22 proteins identified as 
salt-responsive in both 26695 and 7.13 based on label-free spectral counting 
experiments, 10 were identified as salt-responsive in at least one of the two iTRAQ 
analyses (Figure 15D). These included FaaA, FecA3, CagA, fibronectin-domain 
containing protein HP0746, HopQ, and HP0596 (corresponding to tumor necrosis factor 
alpha-inducing protein). Forty one proteins were identified as salt-responsive by at least 
one of the label-free analyses and also by at least one of the iTRAQ analyses (Figure 
15C).   
In addition to the salt-responsive alterations detected in both H. pylori strains, I 
also detected strain-specific responses to changes in salt concentrations (i.e., proteins 
that were identified as significantly different in abundance based on both label-free and 
iTRAQ methods for one strain, but not identified as salt-responsive by either method in 
the other strain) (Tables 8 and 9). For example, the outer membrane proteins HopA and 
HopD, flagellar protein FlaG, and the competence protein ComL were salt-responsive in 
strain 7.13 but not in strain 26695.  In total I identified 13 proteins as salt-responsive in 
one strain but not the other (11 proteins from 7.13 and 2 proteins from 26695) (Tables 8 
and 9). Additionally, I detected strain-specific differences in the directionality of salt-
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induced changes. AmiE was significantly more abundant in strain 26695 grown under 
high salt conditions (based on label-free spectral counting and iTRAQ), whereas AmiE 
was significantly more abundant in strain 7.13 grown under low salt conditions (based 
on label-free spectral counting). I also identified strain-specific differences in effects of 
salt on CheA and Omp8 (HopG), based on a label-free spectral counting approach 
(136). 
 
Changes in abundance of surface-exposed proteins in response to salt concentration 
 The label-free and iTRAQ experiments were performed by analyzing total 
membrane fractions, which contain both inner and outer membrane proteins. I 
hypothesized that, in comparison to analyses of total membrane fractions, low-
abundance salt-responsive proteins present on the bacterial surface might be identified 
more efficiently by analyzing preparations enriched for surface-exposed proteins. 
Therefore, I grew H. pylori in either high salt or low salt concentrations as before, 
labeled surface-exposed proteins of intact bacteria with amine-reactive, cell-
impermeable biotin, and purified the biotinylated proteins.  I first analyzed the 
preparations of purified biotinylated proteins compared to mock preparations from 
control bacteria (not labeled with biotin and grown under normal salt conditions), using 
label-free MudPIT. Among 639 H. pylori proteins detected in these preparations, I 
identified 146 as putative surface-exposed proteins (136), many of which were also 
identified by the same approach in a previous study (135). I next compared the 
biotinylated preparations from bacteria grown in high salt conditions with biotinylated 
112 
 
preparations from bacteria grown in low salt conditions, and identified 21 of the 146 
putative surface-exposed proteins as differentially abundant (Table 10). Most of these 
(15 of 21) were more abundant in the preparations from bacteria grown under low salt 
conditions than in the preparations from bacteria grown under high salt conditions. 
These included VacA-like proteins ImaA (HP0289) and FaaA (HP0609/10), BamA, 
ComH, FecA3, several annotated OMPs (AlpB, HorB, and HP0358), two conserved 
hypothetical secreted proteins (HP0235 and HP1117), and several hypothetical proteins 
(Table 10). Proteins identified as enriched in the high salt preparations compared to low 
salt preparations included HP1124 (a hypothetical protein that may be an outer 
membrane channel, based on BLAST conserved domain search), and fibronectin type 3 
domain protein (HP0746) (Table 10). 
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Table 10. Salt-responsive proteins in strain 26695 identified by analysis of 
biotinylated intact bacteria  
 
Proteins more abundant in low salt compared to high salt 
Accession 
Assigned Spectra Fold difference 
Uniprot KEGG Description Biotinylated 
High Salt 
Biotinylated 
Low Salt 
Unlabeled 
Normal Salt 
Control 
Low vs. 
High 
High vs. 
Control 
Low vs. 
Control 
HP0289 3 20 0 6.58 2.16 13.33 O25063 
Protein 
Binding 
toxin-like outer 
membrane 
protein (ImaA) 
HP0235 8 25 0 3.37 5.25 16.57 O25021 
metabolic 
process 
conserved 
hypothetical 
secreted protein 
HP1117 55 131 5 2.67 3.09 7.7 O25742 NA 
conserved 
hypothetical 
secreted protein 
HP0609* 62 141 18 2.55 1.03 2.46 O25330 
protein 
binding 
toxin-like outer 
membrane 
protein (FaaA) 
HP0913 142 291 25 2.31 1.69 3.63 O25571 NA 
outer membrane 
protein (omp21) 
HP0610*# 153 307 30 2.26 1.52 3.2 O25331 NA 
toxin-like outer 
membrane 
protein (FaaA) 
HP0645* 55 97 2 1.98 6.82 12.6 O25362 NA 
soluble lytic 
murein 
transglycosylase 
(Slt) 
HP1400*# 140 236 9 1.9 4.49 7.95 O25950 transport 
iron(III) dicitrate 
transport protein 
(FecA3) 
HP0358* 155 260 4 1.89 10.47 18.45 O25125 NA 
hypothetical 
protein 
HP1527* 192 314 7 1.84 7.74 13.31 O26055 NA ComH 
HP1333 51 83 1 1.82 10.55 18.01 O25891 NA 
hypothetical 
protein 
HP0655 163 256 12 1.77 3.96 6.55 O25369 
protein 
insertion 
into 
membrane 
BamA 
HP0252 82 123 1 1.68 16.85 26.55 O25034 NA 
outer membrane 
protein (omp7) 
HP1173 163 233 4 1.61 11.04 16.59 O25787 NA 
hypothetical 
protein 
HP0127 161 218 15 1.52 3.17 4.51 O24941 NA 
outer membrane 
protein (omp4) 
          
Proteins more abundant in high salt compared to low salt 
Accession 
Assigned Spectra Fold difference 
Uniprot KEGG Description Biotinylated 
High Salt 
Biotinylated 
Low Salt 
Unlabeled 
Normal Salt 
Control 
Low vs. 
High 
High vs. 
Control 
Low vs. 
Control 
HP1376 16 2 0 5.88 10.22 1.63 O25928 
lipid A 
biosynthetic 
process 
(3R)-
hydroxymyristoyl-
(acyl carrier 
protein) 
dehydratase 
(FabZ) 
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HP1187 36 13 0 2.41 22.59 8.79 O25799 NA 
hypothetical 
protein 
HP1561 68 32 3 1.88 6.05 3.02 O26082 NA 
iron(III) ABC 
transporter, 
periplasmic iron-
binding protein 
(CeuE) 
HP1124# 608 326 10 1.67 17.68 9.99 O25749 NA 
hypothetical 
protein 
HP0746*# 238 140 1 1.52 48.88 30.31 O25442 NA 
fibronectin type 3 
domain protein 
HP0103* 91 53 1 1.52 18.83 11.59 O24929 
signal 
transduction 
methyl-accepting 
chemotaxis 
protein (tlpB) 
* Also significant in label-free analysis of 26695 total membrane preparations 
# Also significant in 26695 iTRAQ experiment  
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Three proteins produced by strain 26695 (FecA3, fibronectin-domain protein 
HP0746, and FaaA) were identified as salt-responsive based on all three of the 
experimental approaches (label-free MudPIT, iTRAQ, and biotinylation) (Figure 15E), 
and 14 proteins were identified as salt-responsive by two of the three methods (Figure 
15E).  In addition to the proteins listed previously (detected by both label-free methods 
and iTRAQ), these included FaaA (HP0609) and three hypothetical proteins (HP0358, 
HP1527, and HP1124).    
 
Salt-dependent changes in bacterial motility 
 Label-free and iTRAQ analysis of strain 7.13 revealed that the abundance of 
multiple proteins associated with flagellar functions was reduced when the bacteria 
were cultured in high salt medium (Table 11). I hypothesized that these shifts in protein 
abundance would have an effect on bacterial motility. To test this hypothesis, we 
analyzed the motility of H. pylori 7.13 in soft agar containing a range of sodium chloride 
concentrations. We observed a significant decrease in bacterial motility in response to 
high salt conditions, and the effect of salt concentration on motility was dose-dependent 
(Figure 17). 
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Table 11. Salt-responsive flagellar proteins from strain 7.13 
Log
2
 R
sc* 
iTRAQ 
ratio** 
Protein 
-1.75 -0.67 Flagellar hook capping protein FlgD 
-1.57 -0.46 Flagellar hook protein FlgE1 
-1.31 -0.82 Flagellar hook protein FlgE3 
-1.75 -0.76 Flagellar hook-associated protein 3 FlgL 
-1.52 -1.05 Flagellar protein FlaG 
-1.02 -0.77 Flagellin A 
-2.16 -0.55 Flagellin FliC 
 
* Calculated using the formula: log2
𝐻+0.5
𝐿+0.5
+  log2
𝑇𝐿− 𝐿+0.5
𝑇𝐻−𝐻+0.5
 . Where H = high salt assigned 
spectra, L = low salt assigned spectra, TH = total high salt spectra, TL = total low salt 
spectra 
** log2 ratio of high salt tag intensity over low salt tag intensity 
 
117 
 
Figure 17. Effect of salt concentration on H. pylori motility.  H. pylori strain 7.13 
was stabbed into Brucella soft agar plates containing 5% FBS, 0.35% agar, and the 
indicated concentrations of added sodium chloride. Diameters of bacterial halos were 
measured after incubation for 5 days. The indicated p values were calculated by 
Student’s T test. 
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Discussion 
 In this study, I used both label-free and iTRAQ methods to identify H. pylori 
membrane proteins that change in abundance in response to alterations in 
environmental salt concentrations. In addition, I analyzed the responses of two different 
H. pylori strains to alterations in salt concentrations. These methods allowed us to 
identify salt-responsive proteins in a given strain by more than one proteomic approach, 
as well as proteins that were salt-responsive in more than one H. pylori strain. 
When comparing the iTRAQ results to the label-free results for a particular strain, 
I was able to confirm approximately 50% of the iTRAQ results by label-free methods 
(Figure 15).  Conversely, a lower proportion of the label-free results was confirmed by 
iTRAQ results. This pattern is attributable to the use of different criteria for identifying 
salt-responsive proteins in the iTRAQ experiments compared to the label-free 
experiments. The differences in iTRAQ and label-free results also reflect distinct 
strengths and limitations of the two approaches. For example, label-free spectral 
counting is optimal for detecting differences in abundance of proteins with many 
assigned spectra, whereas iTRAQ is able to quantify differences in the abundance of 
proteins with fewer assigned spectra.  
In a previous study of strains 26695 and 7.13, 31 salt-responsive H. pylori 
proteins were identified by using 2D-DIGE (81). Several salt-responsive proteins 
identified in the previous 2D-DIGE analysis (for example, CagA, HopQ, FaaA, and 
HP1588) were also identified by multiple methods in the current study. Several other 
proteins designated as salt-responsive in the previous 2D-DIGE analysis (HP0014, 
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HP0221, HP0289, HP0377, HP0630, and HP0680) underwent similar salt-dependent 
changes in abundance in the current experiments, but the changes were not deemed to 
be statistically significant. Multiple factors account for the relatively small numbers of 
salt-responsive proteins identified in both the previous 2D-DIGE study and the current 
study. For example, the current study focused on membrane-associated proteins, 
whereas the 2D-DIGE was performed with whole cell lysate. Another important 
consideration is that 2D-DIGE is suboptimal for analysis of membrane proteins and low-
abundance proteins. The methods utilized in this study permitted an analysis of such 
proteins with a higher level of sensitivity than was possible using 2D-DIGE. Thus, I were 
able to identify several salt-responsive proteins that were not previously demonstrated.  
For example, fibronectin domain-containing protein HP0746 and the outer membrane 
protein FecA3 were shown to be salt-responsive in the current study by multiple 
methods and in two different H. pylori strains. Currently very little is known about the 
function of HP0746. BLAST analysis indicates that this protein contains multiple 
fibronectin type 3 domains, suggesting that HP0746 may function as an adhesin or an 
extracellular glycohydrolase (43, 79). FecA3 is one of several annotated outer 
membrane iron dicitrate transporter proteins. The proteomic data indicate that both H. 
pylori strains analyzed in this study produce three distinct FecA proteins (FecA1, FecA2, 
and FecA3). FecA1 and FecA2 have been previously reported to be regulated by Fur (9, 
134) and the current results indicate that FecA3 is regulated by environmental salt 
concentrations. 
A comparative analysis of strains 26695 and 7.13 identified numerous proteins 
that were salt-responsive in both strains. Recapitulation of the findings in multiple strain 
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backgrounds provides added confidence in the designation of these proteins as salt-
responsive. I also observed 14 examples of strain-specific responses (proteins that 
were identified as salt responsive in one strain based on both label-free and iTRAQ 
methods, but not identified as salt responsive in the other strain by either proteomic 
method). For example, HopA, HopD, FlaG, and ComL were salt-responsive in strain 
7.13 but not in strain 26695. Strikingly, salt had opposite effects on AmiE in the two 
strains (more abundant in high salt conditions for strain 26695 and more abundant in 
low salt conditions for strain 7.13). These strain-specific differences might be 
attributable to the high level of genetic diversity that exists among H. pylori strains. For 
example, there might be variations in nucleotide sequence motifs recognized by salt-
responsive regulators, or there might be variations in the regulatory systems that 
mediate salt-responsive changes. The observed strain-specific variation in results is 
consistent with previous reports of strain-specific responses to environmental stimuli in 
H. pylori (41).  
Previous studies have shown that transcriptional alterations account for the 
changes in abundance of several H. pylori proteins in response to altered salt 
concentration (41, 81, 82). However, it seems possible that some of the observed 
changes may also be mediated by post-transcriptional changes (including changes in 
transcript stability or changes in protein stability). Analysis of promoter regions and 
untranslated regions of genes encoding the salt-responsive proteins identified in this 
study did not readily identify any conserved sequence motifs that might be 
mechanistically involved in the observed salt-responsive changes. Further studies will 
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be required to elucidate the molecular mechanisms underlying the observed salt-
induced changes in abundance of individual proteins.    
My analysis of strain 7.13 revealed that there was a lower abundance of multiple 
proteins associated with flagellar activity when the bacteria were grown in high salt 
conditions. Most of these changes were not detected with strain 26695, which does not 
produce flagella; flagellar hook protein FlgE2 (HP0908) was the only salt responsive 
protein associated with flagellar activity detected in the iTRAQ analysis of strain 26695. 
Concordant with the proteomic data for strain 7.13, we detected decreased bacterial 
motility of this strain under high salt conditions. Previous studies showed that the salt 
concentrations employed in these experiments have minimal effects on the growth rate 
of H. pylori (82), but it is possible that slightly impaired growth at high salt 
concentrations may contribute to the reductions in halo size observed in the soft agar 
assay. Changes in H. pylori motility in response to altered salt concentration could have 
important consequences for the bacteria. For example, if the bacteria are less motile, 
this may impair their ability to move within the mucus layer in response to pH or nutrient 
availability, which could potentially lead to alterations in bacterial load. Studies in mouse 
models have shown that there is typically a reciprocal relationship between H. pylori 
density and severity of the gastric inflammatory response (1), and therefore, alterations 
in the bacterial load may lead to changes in the gastric mucosal inflammatory response. 
In addition, decreased motility may facilitate increased bacterial adhesion to the host 
tissue. Similar to the results of the current study, decreased bacterial motility in 
response to high salt concentrations has also been observed in studies of other 
bacterial species (126). 
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Among the salt-responsive proteins identified in this study, several have 
previously been shown to have important roles in H. pylori colonization of the stomach. 
For example, FecA3 is required for H. pylori colonization of the mouse stomach (9), and 
a faaA mutant was outcompeted by a wild type strain (114). The impaired colonization 
of the faaA mutant may be attributable to flagellar abnormalities and a motility defect 
(114). The functions of most of the other salt-responsive proteins in vivo have not yet 
been studied in any detail.  
In summary, these results provide new insight into the effect of environmental 
salt concentration on the H. pylori membrane proteome.  In future studies, it will be 
important to analyze further the functional consequences of the observed changes in 
protein abundance. In addition to the observed changes in motility that occur in 
response to altered salt concentrations, I speculate that altered abundance of certain 
salt-responsive proteins may enhance the ability of H. pylori to survive salt stress. I 
further speculate that the changes in abundance of surface-exposed proteins that occur 
following exposure of H. pylori to high salt concentrations may lead to altered 
interactions of the bacteria with gastric epithelial cells and immune cells (for example, 
changes in bacterial adherence and changes in production of cytokines), which could 
influence the severity of the gastric inflammatory response. In future studies, it will also 
be important to analyze H. pylori strains isolated from patients who chronically consume 
a high salt diet and determine if these strains exhibit differences in proteomic profiles 
compared to isolates from patients who consume low salt diets.  Ultimately, studies of 
H. pylori responses to altered salt concentrations may lead to a better understanding of 
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the mechanisms by which a high salt diet contributes to an increased risk of gastric 
adenocarcinoma. 
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CHAPTER IV 
 
INVESTIGATION OF CAGT, A PUTATIVE VIRB7 FUNCTIONAL ANALOG 
Introduction 
 As described in Chapter II, three proteins encoded by the cag PAI (Cag3, CagM, 
and CagT) were identified as surface-exposed. Chapter III identified CagT as being salt-
responsive in strain 7.13. Colonization with H. pylori strains encoding the cag PAI is 
strongly associated with the development of gastric cancer (21). The cag PAI encodes 
multiple proteins that are components of a T4SS (Cag T4SS). IL-8 induction and 
extracellular filamentous structure (T4SS pilus) formation when H. pylori is cocultured 
with AGS gastric epithelial cells are two Cag T4SS-dependent phenotypes. Deletion of 
cagT abolishes these phenotypes (59). These data suggest CagT is an essential 
component of the Cag T4SS. The putative function of CagT is inferred by its annotation 
as a VirB7 homolog. However, this annotation is misleading due to the fact that CagT 
has almost no sequence similarity to VirB7. CagT is also much larger in terms of amino 
acid length than VirB7 (280 AA vs. 55 AA). The only sequence similarity CagT has with 
VirB7 is the presence of a 4 AA motif called a lipobox. A lipobox is a predictor of post-
translational lipidation of a bacterial protein. 
 A bacterial lipoprotein is synthesized in several steps. First the newly synthesized 
protein is recognized and secreted via the Sec pathway. Then, before the signal 
sequence is cleaved, the lipidation synthesis machinery recognizes the lipobox. The first 
modification is the addition of a diacylglycerol on the side chain of the conserved 
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cysteine within the lipobox. Then the amino acids preceding the cysteine are cleaved 
via the signal peptidase II (SPII). Finally, a fatty acid is ligated to the amino terminus of 
the cysteine. In order to be localized to the outer membrane, the newly formed 
lipoprotein is ushered across the periplasm to the outer membrane. The canonical 
model of lipoprotein outer membrane localization (based on studies in E. coli) is via the 
localization of lipoproteins (Lol) pathway (70). If the amino acid immediately following 
the modified cysteine is an aspartic acid, this is called a Lol avoidance or inner 
membrane retention signal. The newly synthesized lipoprotein is recognized by the Lol 
machinery and localized to the outer membrane in the absence of the inner membrane 
retention signal. Despite the presence of conserved lipoprotein synthesis machinery in 
H. pylori (132), the model of lipoprotein localization must be viewed with caution 
because only two of the five Lol proteins are present in H. pylori based on sequence 
homology (77). 
 Surface localization of lipoproteins is a process not well understood for most 
bacteria, including H. pylori (70). In this thesis chapter, I describe investigation of CagT 
surface localization and CagT lipidation. I used a genetic approach to investigate the 
effect of lipidation of CagT on known Cag T4SS phenotypes and CagT localization. 
Finally, I expand on the finding from Chapter II that CagT is surface-exposed. To do this 
I used an approach involving intact-cell surface labeling of FLAG-tag insertions into 
CagT to investigate the surface-exposed topology of CagT. 
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Methods 
Bacterial strains and growth conditions 
 H. pylori strain 26695 was grown at 37°C in ambient air containing 5% CO2 on 
either trypticase soy agar plates supplemented with 5% sheep blood, or in sulfite-free 
Brucella broth supplemented with 10% fetal bovine serum (BB-FBS). When selecting for 
mutants, Brucella agar-10% FBS or 5% sheep blood trypticase soy agar plates were 
supplemented with 5 μg/mL chloramphenicol, 15 μg/mL metronidazole, or 10 μg/mL 
kanamycin. Escherichia coli strain MG1655 was grown at 37°C in ambient air on either 
LB plates or LB broth supplemented with 100 μg/mL ampicillin. 
 Bacterial strain mutagenesis 
 Marked cagT mutagenesis  was performed by inserting a cat/rdxA cassette in 
cagT as described previously (59). For unmarked mutagenesis of cagT in H. pylori, the 
genomic region of cagT (HP0532) with 500b flanking sequence (HP0532+500) from 
strain 26695 was amplified using Amplitaq Gold (ThermoFisher) and ligated into 
pGEMT-Easy (Promega) using TA cloning (HP0532+500pGEMT). Using inverse PCR, 
BamHI restriction sites were inserted in the 5’ and 3’ locations of HP0532 (Vent 
polymerase, NEB). HP0532 was then excised using BamHI (ThermoFisher) and the 
vector fragment (containing the HP0532 5’ and 3’ 500b flanking sequences) was gel 
purified. This fragment was circularized using T4 ligase (ThermoFisher) and 
transformed into DH5α. This plasmid was then used to transform 26695ΔrdxA, 
cagT::cat/rdxA, and transformants resistant to metronidazole were selected to generate 
26695ΔrdxA,ΔcagT. Point mutations and FLAG epitope insertions were generated using 
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the HP0532+500pGEMT plasmid with QuikChange Multi site-directed mutagenesis kit 
(Agilent) and transformed into 26695ΔrdxA, cagT::cat/rdxA.  
 Wild type cagT and cagTC21S were introduced in E. coli strain MG1655 by 
insertion in the pBAD vector and selection using ampicillin resistance. Recombinant 
CagT was expressed E. coli strains using arabinose induction.  
Palmitic acid incorporation assay 
 E. coli was grown overnight in 5 mL LB cultures and another 5 mL culture was 
subcultured at a starting Abs600 of 0.1 until the density reached an Abs600 of 0.5. Then 
recombinant CagT was expressed using a final concentration of 0.2% arabinose 
(Sigma), and lipoproteins were labeled using 25 μM palmitic acid alkyne (PA) (Cayman) 
and induced for 4 hours at 37oC. 1 mL of culture was collected and washed twice using 
1 mL PBS. Bacteria were pelleted and frozen at -70oC until needed. 
 Bacterial pellets were resuspended in 200 μL triethanolamine (TEA) with 
lysozyme and Omnicleave (1 μL/mL). Bacteria were incubated on ice for 5 minutes and 
lysed using freeze-thaw (3x). 2 mM final concentration PMSF was then added to the 
lysate. Membranes were solublized using a 0.5% final concentration of SDS. To detect 
labeled lipoproteins, Cyazine 7.5 azide (Cy 7.5) (Lumiprobe) was conjugated to the 
palmitic acid alkyne using a Click-iT labeling kit according to manufactures instructions 
(ThermoFisher). Labeled proteins were visualized using an Odyssey Imaging System 
(Licor). 
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Immunoblotting 
 Protein lysates were resolved using 10% TGX SDS-PAGE gels (BioRad) and 
proteins were transferred to nitrocellulose membranes. Membranes were blocked using 
either 2% milk PBS-Tween 20 (0.1%) or Odyssey blocking buffer (LI-COR) with 0.1% 
Tween 20. Proteins were detected by incubating the membrane with primary antisera 
(diluted 1:5,000-1:10,000), followed by either horseradish peroxidase-conjugated anti-
rabbit IgG (Santa Cruz), horseradish peroxidase-conjugated anti-mouse IgG (Perkin 
Elmer), or IRDye 680RD anti-Rabbit (LI-COR) as the secondary antibody. CagT 
antiserum was preabsorbed to E. coli strain BL21(DE3) prior to immunoblotting. Labeled 
proteins were detected either by ECL methodology and visualized using X-ray film, or 
with immunofluorescence visualized with an Odyssey imaging system. 
IL-8 induction assay 
 AGS cells were grown using RPMI with 25 mM HEPES and 10% FBS and 
cocultured with H. pylori grown overnight in BB-FBS with a MOI of 100. Cocultures were 
incubated for 4 hours at 37oC with 5% CO2. Supernatant was collected and IL-8 
induction was determined using IL-8 ELISA according to manufacturer specifications 
(Biolegend).  
Bacterial subcellular fractionation 
 H. pylori was grown on trypicase soy agar plates for 24 hours and then grown for 
20 hours in Brucella broth to late log phase, corresponding to an OD600 of approximately 
0.8.  Bacteria were pelleted by centrifugation at 3,500 x g for 20 min at 4°C.  The 
bacterial cells were then fractionated as described previously in Chapter II. After 
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fractionation, outer membrane pellets were solublized in RIPA lysis buffer with protease 
inhibitor cocktail (Roche) and boiled for 10 minutes. Insoluble debris was removed via 
spinning at 21,000xg for 10 minutes. Protein concentration was determined via BCA 
assay (Thermo). 
Surface-exposed FLAG tag assay 
 The FLAG epitope (DYKDDDDK) was inserted in various locations throughout 
the length of CagT that were predicted to have low hydrophobicity and thus would be 
more likely to be solvent exposed (27K, 55K, 106K, 110Q, 115R, 145K, 210Y, and 
260L) (Figure 18). H. pylori was grown in 25 mL BB-FBS overnight (Abs600 
approximately 0.5-0.6). Approximately the same number of bacteria were collected and 
processed in parallel. Bacteria were pelleted and washed three times in PBS. 1.5x108 
bacteria were added to a lysine-coated 96-well black-walled plate. For studies with 
permeablized cells, EDTA was added to a final concentration of 10 mM and the bacteria 
were sonicated once at 25% maximum output for 10 seconds. Plates were spun to 
promote bacterial adherence. Bacteria were fixed using paraformaldehyde in PBS at a 
final concentration of 2% and incubated for 10 minutes at room temperature. Non-
adherent bacteria were removed and fixation was quenched three times using TBS. 
Bacteria were blocked using Odyssey blocking reagent (PBS based, LI-COR) for 45 
minutes at room temperature. Bacteria were labeled using anti-FLAG antibody (1:2,500. 
M2 clone, Sigma) for 2 hours. Excess antibody was removed by three washes with PBS 
with 5 minute incubations. The anti-FLAG was labeled using anti-mouse antibody 
(1:1,000, IRDye 800 CW, LI-COR) for one hour. Excess antibody was removed using 
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three washes with PBS with 5 minute incubations. Plates were visualized with an 
Odyssey imaging system. Signal intensity was measured using Image Studio Lite. 
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Figure 18. Sites for CagT FLAG epitope insertion in CagT. Hydrophobicity plot for 
the amino acid sequence of CagT. Red dots indicate positions chosen for FLAG epitope 
(DYKDDDDK) insertion. 
  
132 
 
Super resolution fluorescence microscopy 
 Bacteria were grown in liquid BB-FBS media overnight until the Abs600 was 
approximately 0.7. 1 mL aliquots of culture were collected and pelleted at 3500 x g for 5 
min at 4°C. Bacteria were washed and pelleted 3 times in PBS. The bacterial 
suspension was then concentrated 10 times and spotted on a poly-L-lysine coverslipt 
(Corning). Bacteria were allowed to adhere for 2 minutes at room temperature. Excess 
bacteria were aspirated and adherent bacteria were fixed with 2% PFA in PBS for 10 
minutes. Fixation was stopped by the addition of TBS three times for 5 minutes. 
Coverslips were blocked using Odyssey blocking reagent for 1 hour (PBS based, LI-
COR). The FLAG tag was labeled using 1:1000 M2 anti-FLAG (Sigma) for 2 hours at 
room temperature in blocking buffer. Bacteria were washed with PBS and anti-FLAG 
antibody was detected using anti-mouse Alexa Fluor 546 (Thermo) for 1 hour at room 
temperature in blocking buffer. Bacteria were washed three times in PBS. Bacteria were 
stained using Sybr Green I in PBS for 30 minutes (Thermo). Slides were mounted using 
Prolong Gold (Thermo). Samples were imaged on OMX super resolution microscope 
using 488 nm and 568 nm lasers and a 60x Plan-Aprochromat objective (GE 
Lifesciences). Bacterial dimensions were measured using ImageJ. 
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Results 
Investigation of CagT lipidation status 
 Classically, lipoproteins are identified by either radiolabeled palmitic acid 
incorporation or by a globomycin-dependent SDS-PAGE gel shift. H. pylori does not 
take up palmitic acid (likely due to the lack of a long-chain fatty-acid transporter FadL 
analog) (data not shown) (99), and is not sensitive to globomycin (97). To overcome 
these limitations, I analyzed possible lipid incorporation of CagT expressed as a 
recombinant protein in E. coli (rCagT). E. coli strains expressing CagT were labeled with 
palmitic acid alkyne. Proteins modified with the palmitic acid alkyne were detected via 
conjugation with Cyazine 7.5 azide. Proteins were resolved using SDS-PAGE 
transferred to nitrocellulose membranes. CagT production was determined using CagT 
antisera and fluorescent conjugated anti rabbit immunoglobulin. Cyazine 7.5-coupled 
proteins and immunolabeled CagT was visualized for fluorescence using an Odyessy 
imaging system. Analysis of empty vector pBAD, uninduced E. coli, unlabeled 
cagTpBAD, and non-lipidated cagTC21SpBAD did not reveal a band at the approximate 
size of CagT (30 kDa) for either the Cyazine 7.5 channel or the anti-rabbit fluorescent 
channel.  However, analysis of induced cagTpBAD labeled with palmitic acid did reveal 
a band at the appropriate size for both the Cyazine 7.5 and anti-rabbit channels. In 
addition to the expected size of CagT, CagT antisera also labeled a band of larger size 
in all induced samples (Figure19). The larger CagT band was likely the unprocessed, 
full-length CagT prior to signal sequence cleavage. With the observation that 
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cagTC21SpBAD strain had the larger size band and not the expected size band was the 
phenotype we would expect upon globomycin treatment (97). This suggests the 
cagTC21SpBAD strain only is capable of producing the immature, full-length form of 
CagT and is unable to cleave the amino-terminal signal sequence. Overall, these data 
suggest CagT recombinantly expressed in E. coli is lipidated.  
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Figure 19. Incorporation of palmitic acid into recombinant CagT. E. coli strain 
MG1655 was transformed with either cagT or cagTC21S. Strains were grown until mid-
log, induced with 0.2% arabinose, and lipoproteins were labeled with pamitic acid 
alkyne. Palmitic acid incorporation was detected by labeling cell lysates with Cyazine 
7.5 azide via Click chemistry (PA Cy7.5). N.S.: non-specific band representing loading 
control. 
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Effect of disruption of the lipobox on steady-state levels of CagT 
 The only conserved amino acid within the lipobox motif among different bacterial 
species is a cysteine (7), which is post translationally lipidated. With studies of A. 
tumefaciens, removal of the VirB7 lipobox cysteine resulted in bacteria unable to 
produce a T-pilus (120). With studies of the E. coli VirB/D4 T4SS (Tra T4SS), it has 
been shown that removal of the lipobox cysteine in VirB7 (TraN) results in 
misslocalization of VirB7, VirB9, and VirB10 to the inner membrane (39). Classical 
experiments to determine if a bacterial protein is lipidated (globomycin-dependent SDS-
PAGE size shift and palmitic acid incorporation) have yet to be successful in H. pylori. 
Therefore, direct detection of CagT lipidation in H. pylori is currently impossible. To 
investigate if CagT is lipidated when expressed in H. pylori, I generated a strain of H. 
pylori encoding a gene for CagTC21S (cagT::cagTC21S), similar to what was done 
previously in E. coli with TraN. CagTC21S in this strain was undetectable via immunoblot. 
Sequencing of the gene region confirmed that no secondary mutations in the cagT gene 
were present. In addition to the reduction in steady-state abundance of CagT, the 
CagTC21S strain no longer induced IL-8 upon coculture with AGS gastric epithelial cells. 
These data suggest the steady-state abundance of CagT in this strain was too low to 
allow assembly of a functional Cag T4SS. 
 To rescue this decreased steady-state abundance phenotype, I reintroduced the 
four amino acids corresponding to the CagT lipobox at sites either N-terminal (Rescue 
A) or C-terminal (Rescue B) to the C21S mutation (Figure 20). Both of these strains had 
greater levels of steady-state abundance of CagT compared to the CagTC21S strain. 
Further, both strains were capable of inducing IL-8 upon coculture with AGS cells 
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(Figure 21). These data indicate that reintroducing a wild type (wt) lipobox within 
CagTC21S was sufficient to restore CagT function. 
  
138 
 
 
Figure 20. Schematic of CagT lipidation mutants. CagT: wt CagT sequence with 
intact lipobox motif LSAC. CagTC21S: CagT with cysteine to serine lipobox mutation 
resulting in a predicted non-lipidated form of CagT. Rescue A and Rescue B: Lipobox 
disruption complementation via insertion of wt lipobox sequence either N-terminal or C-
terminal to C21S mutation. 3T: Cag3-CagT fusion, signal sequence of Cag3 replaced 
signal sequence and lipobox of CagT. Construct is predicted to generate a non-lipidated 
form of CagT using the Cag3 secretion signal. Green corresponds to wt CagT 
sequence. Light blue corresponds to wt CagT lipobox sequence. Red corresponds to 
C21S mutation (non-lipidated CagT). Dark blue corresponds to wt Cag3 sequence until 
predicted signal peptidase cleavage site.  
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Figure 21. Rescue of C21S mutation. Top panel: IL-8 levels in supernatant after 4 
hour coculture of AGS cells with indicated H. pylori strains. Bottom panel: CagT and 
HspB immunoblot of whole cell lysates of indicated H. pylori strains. T::C21S: cagT 
replaced by gene for non-lipidated CagT (CagTC21S). Genes encoding Rescue A and 
Rescue B inserted in the cagT endogenous locus. 
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 CagT expressed in E. coli was observed to be lipidated (Figure 19). Disruption of 
the lipobox in CagT resulted in lower CagT steady-state abundance and this strain was 
deficient in IL-8 induction. To investigate whether the reduction in IL-8 induction and 
CagT steady-state abundance were due to loss of CagT lipidation or due to the C21S 
mutation (unrelated to loss of lipidation), I constructed another non-lipidated form of 
CagT. This form of CagT completely lacked a lipobox, and contained a signal peptidase 
I cleavage site instead of a predicted SPII cleavage site. I achieved this by generating a 
gene fusion of nucleotides encoding the body of CagT (AA 22-280) with the secretion 
signal of the Cag3 (AA 1-22) (Figure 20). Cag3 is a protein not predicted to be lipidated 
and is also a surface-exposed Cag protein (Table 3). The resulting fusion was 
designated 3T. Lysate was resolved using SDS-PAGE and abundance of CagT was 
estimated by immunoblotting with CagT antisera. While CagT abundance was below the 
level of detection when immunoblotting 20 μg of lysate, the 3T strain was capable of 
inducing IL-8 when cocultured with AGS cells (Figure 22). While unexpected, this was a 
reproducible result. It is possible that 3T is not detectable via immunoblot because 
CagT antiserum was not able to bind it. However, this is not likely because MudPIT LC-
MS/MS of 3T membrane fractions were also unable to assign spectra to CagT (data not 
shown). Sequence analysis of the gene encoding 3T did not identify any secondary 
mutations. An alternative explanation is that the Cag T4SS requires very few copies of 
CagT to function, and the amount of CagT present, while sufficient for IL-8 induction, 
was below the limit of detection via immunoblot. By developing a much longer exposure 
an overloaded 3T lysate immunoblot, I did detect a very faint band of appropriate size of 
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CagT (Figure 22). These data suggest lipidation is not required for CagT function but is 
required for wt steady-state abundance of CagT. 
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Figure 22. IL-8 induction and immunoblot of non-lipidated CagT. A) Amount of 
cytokine IL-8 in AGS cell supernatant after 4 hour coculture with indicated H. pylori 
strain. B) Immunoblot of 20 μg whole cell lysate using either CagT antisera or HspB 
antisera. Lanes are indicated as in A). C) Immunoblot of whole bacteria using either 
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CagT antisera or HspB antisera. wt = 26695, ΔT = ΔcagT, ΔT / ureA::T = ΔcagT with wt 
cagT expressed in the ureA locus, T::S22D= cagTS22D, T::3T = Cag3-CagT (Figure 20). 
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CagT localization 
 CagT was identified as being surface-exposed using immunogold TEM (Figure 
6). This finding is significant because lipoprotein localization is poorly understood in H. 
pylori, and H. pylori lacks several Lol complex protein homologs. To investigate whether 
CagT is shuttled to the outer membrane in a Lol-dependent pathway, I inserted a 
canonical +2 Lol-avoidance point mutation (CagTS22D) in the cagT endogenous locus. 
CagT from this strain was detected by immunoblotting in similar abundance compared 
to the wt strain (Figure 22). Further, CagTS22D was found in the Triton-insoluble outer 
membrane fraction similar to wt CagT (Figure 23). This may suggest that either CagT 
uses a Lol-independent localization pathway, the H. pylori Lol-avoidance mechanism is 
non-canonical, or that H. pylori lacks a functional Lol complex.  
 Independent of the Lol complex, proper localization of CagT may be dependent 
on other Cag proteins. To investigate this, I inserted cagT in the ureA locus of a 
26695ΔPAI strain (Figure 24). CagT in this strain localized to the outer membrane, 
similar to its localization in wild type bacteria. This suggests CagT localization is 
independent of other Cag proteins. However, a comparison of the α CagT / α HspB 
signal ratios of ΔT/T (1.8) and ΔPAI/T (0.4) suggested that some element of the cag PAI 
is required for full wt levels of steady-state CagT (Figure 24).  
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Figure 23. Triton subcellular fractionation of wt H. pylori and CagTS22D. Both panels 
are immunoblots for CagT. 25 μg total protein was loaded into each lane. CP: 
cytoplasmic fraction (detergent-free soluble lysate), TM: total membrane fraction 
(detergent-free insoluble lysate), IM: inner membrane fraction (Triton-X100 soluble TM 
lysate), OM: outer membrane fraction (Triton-X100 insoluble TM lysate)  
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Figure 24. Localization of CagT in a ΔPAI background. Top: immunoblot of cellular 
fractionations for indicated H. pylori strains. WC fraction is lysate from wt and ΔPAI 
strains, CP,PP, IM, and OM fractions were generated with ΔT/T and ΔPAI/T strains. 
Bottom: densitometry of the α CagT signal / α HspB signal for each lane. CP: soluble 
protein lysate (cytoplasmic fraction), IM: Triton-soluble total-membrane fraction (inner 
membrane fraction), OM: Triton-insoluble total-membrane fraction (outer membrane 
fraction), WC: whole cell lysate. wt: unmodified strain 26695, ΔT: clean deletion of cagT 
(HP0532),  ΔT/T: clean deletion of cagT with cagT complemented in cis (ureA::cagT), 
ΔPAI/T, cag PAI::chloramphenicol resistance cassette (cat) with cagT complemented in 
cis (ureA::cagT). 
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CagT surface topology 
 To characterize the surface-exposed topology of CagT, I inserted a FLAG 
epitope (DYKDDDDK) in various locations within CagT that were predicted to have low 
hydrophobicity (Figure 18). The resulting strains were named for the amino acid number 
and residue name immediately preceding the FLAG-tag insertion. Each H. pylori strain 
was cocultured with AGS gastric epithelial cells for 4 hours at an MOI of 100 to 
determine if insertion of the FLAG epitope disturbed Cag T4SS function (Figure 25). 
Strains 27K and 260L had similar steady-state levels of CagT compared to wt, and had 
a similar IL-8 induction phenotype. Strain 210Y had wt levels of CagT, but was unable 
to induce IL-8. Strain 145K had slightly less steady-state levels of CagT, but was still 
capable of wt levels of IL-8 induction. Strain 55K had similar steady-state levels of CagT 
compared to strain 145K, but unlike 145K, 55K was unable to induce IL-8. Strains 106K, 
110Q, and 115R had very low steady-state amounts of CagT and were unable to induce 
IL-8 (Figure 25).  
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Figure 25. CagT steady-state abundance and IL-8 induction phenotype. Top: IL-8 
induction of AGS cells after 4 hour coculture with an MOI of 100. Bottom: immunoblot 
for CagT and HspB. Numbers and letters correspond to preceding amino acid number 
for FLAG insertion.  
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 Immunolabeling of intact bacteria from the FLAG-tag CagT panel identified the 
27K epitope as being surface-exposed. After permeabilizing cells with 10 mM EDTA 
and sonicating once, the remaining FLAG-tagged strains reacted with the anti-FLAG 
antibody, whereas the cagT knock out complemented with wt cagT did not (Figure 26). 
This suggests the labeling was specific and the FLAG tag from the other strains was still 
solvent-exposed, just inaccessible under non-lytic conditions (Figure 26). 27K is within 
close proximity to the predicted post-translational lipidation site (C21). It is likely that the 
lipid moiety is inserted within the outer-leaflet of the outer membrane. Overall these 
results suggest CagT is a transmembrane lipoprotein, with its amino-terminus localized 
on the extracellular side of H. pylori and its carboxy-terminus localized within the 
periplasmic space (Figure 27).  
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Figure 26. Intact cell immunolabeling of FLAG-tagged strains. Top: either intact 
cells (cell surface) or lysed (lysate) cells were applied to a lysine coated 96-well plate 
and probed with α FLAG antibody. Panel is representative image of duplicated samples. 
Bottom: average signal intensity from the lysed cells subtracted from the cell surface 
wells. All strains are from a ΔcagT background. Complementation of the ΔcagT was 
achieved by insertion nucleic acid sequence encoding either wt CagT (T/T), or FLAG-
tagged CagT, in the ureA locus. Intact bacteria were bound to plates in PBS, 
permeablized bacteria were sonicated in PBS with 10 mM EDTA. FLAG tag was 
detected using anti-FLAG immunoglobulin (Sigma) and anti-mouse IRDye 800 CW, LI-
COR. Signal intensity was measured using Image Studio Lite (LI-COR). 
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Figure 27. Proposed model of CagT topology. Blue oval: predicted lipoprotein post-
translational modification. C21 and K27: amino acid positions, EX: extracellular, OM: 
outer membrane, PP: periplasm. 
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 In Chapter II I confirmed CagT was surface-exposed using immunogold TEM 
(Figure 6). I observed CagT labeling as occurring in clusters. This was subsequently 
confirmed by another group (122). To further study this clustering phenotype I 
conducted studies with the FLAG-tagged CagT strain K27. By using super-resolution 
fluorescence microscopy I observed a FLAG tag distribution pattern with the strain K27 
similar to CagT in wt bacteria. These results suggest CagT in the strain K27 distributes 
throughout H. pylori similar to the CagT distribution pattern I previously observed in wt 
bacteria (Figures 6 and 28).  
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Figure 28. Super resolution of FLAG-tagged strain 27K in pure culture. Bacteria 
were fixed and labeled using anti-FLAG M2 (Sigma) and imaged on OMX super 
resolution microscope with a 60x Plan-Aprochromat objective (GE Lifescience). Green: 
Sybr Green I, red: anti-mouse Alexa Fluor 546, blue box: outline of single H. pylori 
bacteria, white bar = 1 μm. Typical dimensions of H. pylori: 2-4 μm x 0.5-1 μm. 
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Discussion 
 In this study I investigated the effect of post-translational modification on the 
localization and activity of the lipoprotein CagT, and also investigated CagT surface 
topology. I conclude that CagT, like VirB7, is most likely a lipoprotein based on studies 
of recombinant CagT in E. coli strain MG1655. Upon induction of CagT production, 
there was also a palmitic acid – cyazine 7.5 (PA Cy7.5) band of approximate size to 
expected size of CagT. CagT antiserum also labeled a similar sized band. This 
suggests recombinant CagT incorporated the palmitic acid. A strain producing lipidation-
deficient CagTC21S was unable to produce this palmitated band. This result suggests the 
C21 of CagT is the site of lipidation. Direct detection of such a modification in H. pylori is 
impossible due to its inability to take up palmitate (several attempts were unsuccessful), 
as well as being resistant to the signal peptidase II inhibitor globomycin (97). 
 Mutation of the cysteine predicted to be the site of post-translational lipidation 
results in a significant reduction in steady-state amounts of CagT. This C21S mutation 
also resulted in the inability of H. pylori to induce IL-8, similar to a clean cagT deletion 
(Figures 21 and 22). The abundance of CagTC21S was too low to be detectable via 
immunoblot. Wild type phenotypes can be restored upon addition of the four amino acid 
wild-type lipobox either before or after the C21S substitution. Another strain that 
encoded a predicted non-lipidated CagT (designated 3T) had a steady-state level of 3T 
almost below the level of detection with immunoblot. Despite the inability to detect 3T at 
CagT wt levels on an immunoblot, this strain was still able to induce IL-8 production 
upon coculture with AGS cells. This suggests while the steady-state abundance of 3T is 
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very low, the few copies of 3T are functional. I can conclude that CagT does not require 
lipidation for function. However, lipidation of CagT is required for wild type steady state 
abundance of CagT. 
 Outer membrane localization of the E. coli lipoprotein Lpp requires the Lol 
complex (131). Lipoproteins with an aspartic acid immediately after the lipidated 
cysteine (often referred to as the Lol avoidance signal) will be retained in the inner 
membrane (140). When I substituted the +2 amino acid of CagT with an aspartic acid 
(CagTS22D), I still detected CagT in the outer membrane. To investigate the possibility of 
CagT localization being a Cag-dependent function, I inserted cagT within the ureA locus 
in a strain of H. pylori missing the entire cag PAI. Like the CagTS22D strain, this 
ΔPAI/cagT still localized CagT properly. This suggests proper localization of CagT 
requires an endogenous cellular process of H. pylori, likely to be required for localization 
of other non-Cag lipoproteins. Although insertion of a canonical Lol-avoidance signal 
had no effect on CagT OM localization, it is possible that CagT may be utilizing the Lol 
machinery. Other residues may be required for inner membrane retention (74). 
Previously, I have identified the hypothetical protein HP1457 as an inner membrane 
protein (135). This protein is predicted to be a lipoprotein based on the presence of a 
canonical lipobox and predicted signal peptidase II cleavage site. The +2 residue for 
HP1457 is not an aspartic acid; like CagT, the +2 residue is a serine. This would 
suggest H. pylori may use an alternative Lol-avoidance signal. For example, one group 
reported that the +3 and +4 residues are determinants of lipoprotein inner membrane 
retention in Pseudomonas aeruginosa (94). Future studies would be needed to 
investigate the possibility of novel inner membrane retention signals in H. pylori.  
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 CagT is capable of outer membrane localization in a ΔPAI background. However, 
comparing the α CagT / α HspB signal ratios of of ΔT/T and ΔPAI/T suggested that full 
wt levels of steady-state CagT requires an unknown element of the cag PAI. These data 
conflict with a previous study that used isogenic knockouts of different cag genes (72). 
Results of the previous study suggested steady-state amounts of CagT did not depend 
on the presence of Cag3, Cag4, VirB11, CagY, CagX, CagW, CagV, CagU, CagM, 
CagL, CagH, CagE, or CagC. However, this represents approximately half of the 
predicted Cag proteins encoded in the cag PAI. Other proteins may be required for the 
maintenance of steady-state abundance of CagT. Further, it is possible that an 
untranslated element influences transcript abundance, transcript stability, or translation 
efficiency. Future studies are needed to investigate these possibilities further. 
 My data suggest CagT is a surface-exposed lipoprotein. Outer membrane sorting 
of lipoproteins in ε proteobacteria is poorly understood. Surface localization is especially 
confounding as no shared system for surface localization of lipoproteins present across 
bacterial species has been described. While CagT immunogold TEM suggests CagT is 
surface-exposed, it was unclear if CagT was entirely surface-exposed, or only partially. 
Using FLAG-tagged CagT, I have shown that at least the amino-terminal domain of 
CagT, near the predicted site for lipidation, is surface-exposed, while the carboxy-
terminus of CagT is not surface-exposed.  
 Overall, these studies strengthen our knowledge of CagT, an essential element 
of the Cag T4SS. More broadly, these studies may help guide future studies into how a 
surface-exposed lipoprotein is localized properly in H. pylori. Previous studies have 
identified several lipoproteins as being required for colonization of host tissue. 
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Investigation into the mechanism of lipoprotein synthesis and localization may help 
identify a potential therapeutic drug target for the treatment of H. pylori.  
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CHAPTER V 
CONCLUSIONS 
Summary  
 Helicobacter pylori is a human gastric bacterium that currently colonizes 
approximately half of the world’s population. Colonization usually occurs in childhood, 
can persist lifelong, and is a strong risk factor for development of peptic ulcers or gastric 
cancer. There are many factors that influence disease outcome. These include host 
genetics, environmental conditions (host diet), and bacterial genetic makeup.  
 H. pylori is a very genetically diverse organism. Human migration has been 
mapped by analyzing the genetic profile of H. pylori strains from different geographically 
distinct locations (31). Strains of H. pylori that contain certain genetic elements, such as 
the cag PAI and the gene encoding s1m1 VacA, are associated with adverse clinical 
outcomes, compared to strains that lack these features (21).  
 Other major H. pylori virulence-associated factors are specific OMPs such as 
BabA and SabA (88, 93). These OMPs function as adhesins. BabA binds fucosylated 
Lewis b antigens and SabA binds Lewis x antigens. The amino-terminal domains of 
both BabA and SabA have recently been crystallized. Both have similar structures, 
characterized by a “golf club” like appearance. The “handle” domain connects the 
extracellular “head” domain to the carboxy-terminal β-barrel (106). The respective Lewis 
antigens bind at the top of this “head” domain (46). Considering the gastric environment 
where H. pylori colonizes, adhesion to host tissue is an important biological function. 
The bacteria must avoid being shed with the continual turnover of the gastric mucus 
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layer to prevent being exposed to the low pH of the gastric lumen. By having strong 
adhesive properties, the bacteria minimize this risk. Other OMPs with amino acid 
sequences similar to BabA and SabA are HopQ, BabB, SabB, HopZ, and OipA (HopH). 
These OMPs are also associated with pathogenesis (98). While these proteins all have 
similar amino acid sequences (primarily within the carboxy-terminal domain) (3), it is 
currently not known if any of these proteins function as adhesins or if these OMPs have 
other biological functions. 
 While we can use sequence analysis to find genetic elements associated with 
disease, it is unknown if these gene products are localized to the bacterial surface. The 
bacterial surface is the interface between host and pathogen and likely to contain many 
virulence determinants. Previous studies have attempted to identify surface-exposed 
proteins in H. pylori (118, 119). However, these studies often only employed a single 
approach.  In order to more confidently identify surface-exposed proteins, I used 
multidimensional approach described in Chapter II (on-cell biotinylation, multiple cellular 
fractionations, and protease susceptibility). By combining several approaches in the 
same study, I was able to identify 45 putative surface-exposed proteins, more 
confidently than if I only used a single approach. Thirty-nine surface-exposed proteins 
were identified using on-cell biotinylation coupled with multidimensional cellular 
fractionation. Five additional proteins were identified by combining protease-
susceptibility with on-cell biotinylation and 1 of 2 methods of cellular fractionation. VacA 
was identified as surface-exposed by coupling proteinase-K susceptibility with both 
membrane fractionation methods. Of the thirty-nine identified proteins, thirteen (32%) 
were annotated as either Hop (12 of 13) or Hop-related (1 of 13) OMPs. Seven OMPs 
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from other families were also identified. Four were from family 4 (iron-regulated) and 
three were from the “other” category.  
 I was also able to characterize the surface topology of several outer membrane 
proteins. Seven of the thirteen family 1 OMPs identified using the biotinylation and 
fractionation approaches were susceptible to digestion by an extracellular protease. An 
additional five protease-susceptible OMPs (4 Hop, 1 Hom) were not among the proteins 
identified using the multidimentional approach (BabC, HopA, HomA, HopM, and HopN). 
While 12 were considered significant by topology mapping criteria described in Chapter 
II, 21 of the 36 annotated Hop, Hop-related, Hom, and Hof families of OMPs displayed 
some level of protease susceptibility. All proteins from the Hop OMP family identified 
using the biotinylation and fractionation methods were identified as having some 
amount to protease susceptibility. Based on these results, it is clear many proteins in 
the Hop OMP family possess an extracellular domain that may be interacting with the 
extracellular environment and possibly making direct contact with the host. Future 
studies will be needed to expand on these findings including efforts to determine 
whether these proteins function as adhesins and what their binding targets are. 
 In Chapter III of this thesis. I identified salt-responsive membrane proteins of H. 
pylori. One of the environmental conditions associated with adverse outcomes of H. 
pylori infection is high dietary salt. While the host may undergo physiological changes in 
response to high salt conditions, I was interested in identifying salt-induced changes in 
H. pylori membrane protein abundance. I hypothesized proteins that changed in 
abundance in response to environmental salt (a known condition associated with an 
increased risk in the development of gastric cancer) may contribute to pathogenesis. 
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Sequence analysis of pathogenic vs non-pathogenic strains may identify potential 
virulence factors that are present in one strain and absent in another. However, what if 
a specific protein only contributes to virulence when steady-state abundance is altered? 
Sequence analysis would identify the gene encoding this protein in both pathogenic and 
non-pathogenic strains and thus would not be readily identified. 
 I focused this study on membrane proteins because this cellular fraction would 
contain the surface-exposed proteins identified in Chapter II. I used a multidimensional 
proteomic approach to identify salt-responsive membrane proteins. Specifically, I 
combined label-free Multidimensional protein identification technology (label-free 
MudPIT) with isobaric tag for absolute protein quantification (iTRAQ). I analyzed both 
the laboratory strain 26695 and the infection model strain 7.13 and assayed for proteins 
significantly changing in abundance in response to environmental salt.  
 I was able to identify a variety of proteins that were changing in abundance in 
response to environmental salt using this approach. Approximately half of the proteins 
identified as salt responsive using iTRAQ were also identified as significantly different in 
abundance between the two salt conditions using label-free MudPIT (Figure 16). Upon 
further analysis of the data, I noticed that vast majority of proteins identified using both 
methods were trending in the same direction (Figure 16). This emphasizes the power of 
our statistical analysis methods, giving us greater confidence in our list of salt-
responsive proteins.  
 By comparing these results to the identified surface-exposed proteins in Chapter 
II, I identified three surface-exposed salt-responsive proteins in strain 26695 and five in 
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strain 7.13. Two salt-responsive surface proteins identified in both strains were the 
iron(III)-dicitrate transport protein FecA3 (also an OMP from the iron-regulated OMP 
family) and putative lipoprotein HP0746. FecA3 has been previously reported as being 
required for animal colonization. FecA3 had fewer assigned spectra from bacteria grown 
in high salt conditions compared to bacteria grown in low salt conditions. Animals with a 
high salt diet and infected with H. pylori developed a stronger inflammatory response 
than animals with a normal salt diet or uninfected animals (40). It is possible that 
changes in bacterial protein abundance influence this disease outcome. Based on 
FecA3 having fewer assigned spectra in high salt conditions, I speculate that FecA3 can 
be anti-inflammatory, or make the bacteria less adhesive to host tissue in higher 
abundance. The hypothetical protein HP0746 has a canonical lipobox so it is predicted 
to be lipidated. This protein was identified as having a greater number of assigned 
spectra in the high salt conditions compared to the low salt conditions. HP0746 also 
contains a multidomain identified by NCBI BLAST as a fibronectin type III domain (not to 
be confused with a fibronectin binding domain). Bacterial proteins with this fibronectin 
type III domain have been studied in gram positive organisms and these proteins may 
have enzymatic properties (64). In contrast to the speculation that FecA3 may be less 
inflammatory in higher concentrations, it is possible that HP0746 is proinflammatory. 
The increased abundance of HP0746 in high salt may be contributing to the increased 
host pathology with this condition. The VacA-paralog FaaA was identified as salt 
responsive in strain 26695 and HopD, HopQ, and CagT were identified as salt-
responsive in strain 7.13.  
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 Strain 26695 does not produce flagella, but strain 7.13 does. Several proteins in 
strain 7.13 with flagellar function annotations were identified as more abundant in low 
salt conditions than high salt conditions (Table 11). I hypothesized that due to the 
decreased abundance of flagellar proteins in high salt conditions, H. pylori would be 
less motile in a high salt environment. We used a soft agar colony diffusion assay to test 
this possible motility phenotype. In agreement with my hypothesis, I observed a reduced 
colony diameter under high salt conditions compared to low salt conditions (Figure 17). 
It is possibly that by reducing motility, H. pylori would be more adherent to host tissue 
under high salt conditions. Overall, these studies greatly expanded our knowledge on 
how the membrane proteome of H. pylori changes in response to environmental salt 
concentrations.  
 Chapter IV investigated CagT, a surface-exposed component of the Cag T4SS. 
In Chapter II, CagT was identified as surface-exposed using a multidimensional 
proteomic approach, and was confirmed using immunogold TEM. In Chapter III, CagT 
was identified in strain 7.13 as being salt-responsive (more abundant in high salt using 
label-free MudPIT and iTRAQ). Prior to my experiments in Chapter IV, there was very 
little data about any aspect of CagT, and much of its function was inferred because of a 
VirB7 annotation. This annotation was based solely on the presence of a shared four 
amino acid motif (named a lipobox) found in both CagT and VirB7. A lipobox is a 
predictor of post translational lipidation. However, the lipobox is the only distinguishing 
feature shared between CagT and VirB7. The most obvious difference between CagT 
and VirB7 is the length of the amino acid sequences. VirB7 is 55 amino acids in length 
while CagT is 280 amino acids in length.  
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 CagT is required for all currently known Cag T4SS-dependent phenotypes. This 
highlights the importance of CagT for the activity of the Cag T4SS. My studies of CagT 
centered around two themes: investigation of the putative lipobox, and the surface-
exposed topology of CagT. The significance of these studies is highlighted by the fact 
that surface-exposed lipoproteins are an emerging field of bacteriology and recently 
have been gaining appreciation for their importance in bacterial physiology and 
pathogenicity (70, 71, 113, 139). 
 Lipoproteins are classically identified by two main methods, globomycin 
sensitivity and palmitate incorporation. Unfortunately, H. pylori is resistant to globomycin 
and does not take up palmitate. I employed studies with recombinant CagT in order to 
investigate whether CagT is indeed a lipoprotein. I recombinantly expressed CagT in 
the E. coli strain MG1655 and labeled lipoproteins using labeled palmitate. I was able to 
identify rCagT (recombinant CagT) as being lipidated. I used a genetic approach to 
further study the lipidation of CagT in H. pylori. Previous studies of the lipoprotein VirB7 
described how replacing the lipid-modified cysteine with a serine resulted in a 
misslocalization phenotype (39). In my studies, this same mutation in CagT resulted in 
CagT no longer being detectable via immunoblot (Figures 21 and 22). This reduced 
steady-state CagT was rescued by insertion of the four amino acid lipobox either before 
or after the disrupted lipobox. Further, a predicted non-lipidated fusion of the Cag3 
signal sequence (predicted signal peptidase I cleavage site) to the CagT sequence 
beyond the lipobox was poorly detectable via immunoblot. These data suggest the 
lipobox is required for steady-state abundance of CagT. While CagT was undetectable 
via immunoblot in the strain expressing a Cag3-CagT fusion, this strain was still capable 
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of inducing IL-8 upon coculture with AGS cells, suggesting that it possessed a functional 
Cag T4SS, a surprising but reproducible phenotype. This result suggests lipidation of 
CagT is not required for its function and indicates that lipidation is required for steady-
state abundance of CagT.  
 I also investigated the surface topology of CagT. I inserted an eight amino acid 
FLAG epitope (DYKDDDDK) at multiple sites throughout the length of CagT in regions 
of predicted low hydrophobicity (Figure 18). Immunoblotting of each of these CagT-
FLAG strains for CagT identified the middle region of CagT as a region required for 
intact steady-state abundance of CagT (Figure 25). Strains 55K, 106K, 110Q, 115R, 
and 145K all had lower steady-state abundance of CagT compared to unlabeled CagT. 
Strains 27K, 210Y, and 260L had steady-state abundance of CagT similar to unlabeled 
CagT. Using these strains, I identified only the amino terminus of CagT (27K) as being 
surface-exposed (Figure 26). Because 27K is very close to the predicted SPII cleavage 
site (predicted SPII cleavage occurs between residues 20 - 21), it is likely the lipid 
modification is localized to the outer leaflet of the outer membrane (69).  
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Future Directions 
 
Impact of surface-exposed OMPs on pathogenesis 
 The importance of the studies described in this thesis is based on the premise 
that surface-exposed H. pylori proteins influence disease outcome. This premise is 
based on the observation that OMPs BabA and SabA are known adhesins and patients 
colonized with H. pylori strains expressing these and other closely related OMPs have 
an increased risk of gastric cancer or peptic ulcer disease. In Chapter II, I identified 44 
putative surface-exposed outer membrane proteins in H. pylori. Annotated OMPs were 
the most abundant family of proteins identified in Chapter II. Many of the identified 
OMPs (BabA, BabB, BabC, HopA, HopB, HopC, HopF, HopH, HopM, HopN, HopQ and 
HomA) displayed significant sensitivity to an extracellular protease, suggesting the 
presence of extensive extracellular domains. HomD was also identified as being 
protease-susceptible due to an observed decreased in total assigned spectra after 
protease treatment. However, there was insufficient spectral coverage for the topology 
mapping analysis described in Chapter II. With studies of BabA and SabA, the adhesive 
properties of these proteins have been found to be localized within the amino-terminal 
domain. Many of the OMPs identified in Chapter II have sequence similarity at the 
carboxy-terminus and sequence variability at the amino-terminus. I observed the 
protease-sensitivity specifically at the amino-terminus of these OMPs, suggesting the 
amino-terminal domain is exposed at the extracellular side of the outer membrane. 
Based on this, I hypothesize that many of the OMPs identified in Chapter II that display 
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significant protease-sensitivity also function as adhesins, similar to BabA and SabA. As 
a future approach to test this hypothesis I would generate a mutant panel for each of the 
12 identified protease-susceptible OMPs. Each of these mutants could be tested for 
adhesive properties in either animal model or human stomach explant tissue samples 
(88). Mutant H. pylori that are less adherent to these tissue samples would be 
candidates for competition assays with wildtype bacteria in an animal model. Mutant 
bacteria that are significantly less abundant in the stomach after infection would suggest 
the corresponding OMP is likely acting as an adhesin. 
 A separate but related approach could be used to identify host cell receptors for 
H. pylori OMPs. BabA and SabA bind Lewis b and Lewis X antigens. Both antigens are 
carbohydrates. It is likely that other adhesive OMPs share this carbohydrate binding 
property with similar antigens. To identify putative host cell receptors for additional 
protease-susceptible OMPs, the OMP mutant panel deficient in production of the twelve 
protease-susceptible OMPs could be used in the screening of a mammalian glycan 
array. Candidates would be confirmed using adherence assays for cell lines (capable of 
expressing or unable to produce these glycans). 
  
Effect of salt-responsive proteins on pathogenesis 
 I identified several surface-exposed proteins as being salt-responsive. However, 
it is unknown if the identified salt-responsive proteins influence host diet-dependent 
pathogenesis in vivo. A possible experiment to address this would be to infect animals 
with mutant strains of H. pylori deficient in the production of the identified salt-
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responsive proteins. Priority would be given to salt-responsive proteins identified in both 
26695 and 7.13 (FecA3 and HP0746). H. pylori mutant strains harboring mutations in 
these genes could be used for a competition assay with wild type bacteria in animals 
fed either high or low salt diets. 
 
Further studies of salt-responsive changes in protein abundance 
 We identified several proteins changing in steady-state abundance in response 
to environmental NaCl concentration. Is the change due to the Na+, Cl-, or a more 
generally osmotic stress response? To investigate this, I propose comparing H. pylori 
grown with NaCl to bacteria grown in the presence of other salts, such as KCl (as a 
source of Cl-) or sodium bicarbonate (as a source of Na+). Generalized osmotic stress 
can be induced using a salt lacking both the sodium and the chloride, such as lithium 
carbonate. Each of these culture conditions could be applied in a study similar to 
Chapter III. The salt-responsive proteins identified in Chapter III could be compared to 
proteins identified as changing in relative abundance using these alternative additives. 
This would allow us to classify proteins as being either sodium-responsive, chloride-
responsive, or as changing in abundance in response to osmotic stress. These studies 
may help us identify the specific stimuli responsible for the observed changes in protein 
abundance and guide future investigations of the mechanism of how H. pylori responds 
to environmental conditions. 
 While we were able to identify several proteins changing in abundance in 
response to environmental salt concentration, it is unknown whether the observed 
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changes are a result of changes in transcription or other alterations. I propose to 
perform RNA-Seq on H. pylori grown under the conditions from Chapter III. Changes in 
transcription identified with RNA-Seq may then be further validated by multiple reaction 
monitoring (MRM) LC-MS/MS. Ultimately an important goal is to define mechanism by 
which H. pylori alters protein abundance in response to changes in environmental salt 
concentration. Differentiating between transcriptional-dependent and transcriptional-
independent changes in salt-responsive proteins is an important step toward this goal. 
An additional approach would be to utilize protein network databases. Proteins 
predicted to be involved in similar pathways or protein-protein interactions also identified 
as being salt-responsive would be a strong rationale for further investigation. 
 Another environmental additive that deserves further study is monosodium 
glutamate (MSG). I suggest this because areas of the world with high salt diets that 
correlate with higher levels of gastric cancer are generally also areas of the world that 
consume higher levels of MSG. Additionally, glutamate is an intermediate of the citric 
acid cycle (glutamate is converted to α-ketoglutarate by glutamate dehydrogenase). The 
extra glutamate in MSG may alter the metabolic activity of H. pylori, thus stimulating 
changes in protein abundance. Additionally the conversion of glutamate to α-
ketoglutarate by glutamate dehydrogenase produces ammonia, which may aid H. pylori 
survival in the acidic environment of the stomach.  
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Is CagT a lipoprotein in H. pyloiri? 
 CagT expressed in E. coli strain MG1655 appears to be lipidated based on a 
palmitic acid incorporation assay. Other groups who previously investigated lipidation of 
H. pylori proteins performed experiments based on analysis of recombinant proteins 
(97, 99). To my knowledge, no group has been able to directly analyze lipidation in H. 
pylori. This is likely due to H. pylori being insensitive to globomycin (SPII inhibitor) and 
unable to take up pamitate (97, 99)(data not shown). One preliminary approach to 
identify post-translational lipidation in H. pylori would be to treat H. pylori lysate with a 
lipase to cleave the diacylglycerol on the modified cysteine side chain. Then it would be 
possible to assay for a decrease in size (expected decrease of about 0.5 kDa) of CagT 
via immunoblot. This would provide preliminary evidence of CagT lipidation in H. pylori. 
Spectra of lipase-treated and untreated CagT could be compared for further validation. 
 
H. pylori localization of surface-exposed lipoproteins 
 Experiments showing immunogold and FLAG-tag labeling of CagT in intact H. 
pylori provide evidence that CagT is surface-exposed. Localization of lipoproteins to the 
bacterial surface is a little understood process. Expression of CagT in a strain of H. 
pylori deficient for the cag PAI still shows CagT localized to the Triton X-100 insoluble 
outer membrane fraction. This suggests CagT does not require other Cag proteins for 
proper localization. It is likely CagT is localized to the outer membrane by a cellular 
process also utilized by other H. pylori lipoproteins. Flagellar sheath protein HpaA 
(HP0797) and “a secreted protein involved in flagellar motility” (HP0232) are other 
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putative H. pylori lipoproteins (7, 97). Genes encoding both HpaA and HP0232 have 
been described as being required for colonization (65). This suggests that inhibition of 
lipoprotein processing in H. pylori may be a novel therapeutic approach. An approach to 
identify a possible localization chaperone would be to immunopurify CagT and identify 
proteins coenriched. Assuming genes that are required for colonization are not essential 
for bacterial survival, another approach would be to screen a mutant H. pylori library for 
strains that no longer properly localize CagT on its surface, by magnetic-associated cell 
sorting (MACS). Strains without antibody labeled CagT would be analyzed via deep 
sequencing for identification of disrupted genes that may be involved in lipoprotein 
localization. Candidate genes would be disrupted via site-directed mutagenesis and 
CagT localization would be analyzed by cellular fractionation and on-cell 
immunolabeling. 
Localization of CagT in coculture 
 Images generated from scanning electron microscopy of H. pylori in coculture 
with gastric epithelial cells have revealed filamentous structures (Cag T4SS pili) at the 
host-bacterial interface (96, 124). Immunogold TEM of CagT from H. pylori grown in 
pure culture showed labeling of CagT on the bacterial surface. It is unclear whether Cag 
proteins change localization in response to contact with host cells, or if Cag T4SS pili 
only form at Cag T4SS cores in close proximity to the host tissue. Use of the FLAG-
tagged CagT strain 27K would be a way to begin to investigate whether CagT changes 
its distribution on the surface of H. pylori in response to host-cell contact. By using 
immunofluorescence (Figure 28) or immunogold microscopy, I would compare CagT-
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FLAG surface labeling in H. pylori in pure culture to bacteria in coculture with AGS 
gastric epithelial cells.  
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Last Remarks 
 An in-depth knowledge of the composition of the bacterial surface is important for 
understanding how a bacterium interacts with its environment and how pathogens 
cause disease in the host. Many virulence determinants are present on the bacterial 
surface and are within close proximity to the host. H. pylori encodes many OMPs that 
are associated with pathogenesis and two of these OMPs are known adhesins, BabA 
and SabA. There are approximately 30 OMPs with a large amount of sequence 
similarity to BabA and SabA (OMP family 1). Protease-susceptibility assays and 
structural studies (crystallography) suggest these and other related OMPs possess a 
large extracellular domain and are likely interacting with host tissue. Further study of the 
OMPs identified in this thesis is important for advancing our understanding of how H. 
pylori interacts with the host and ultimately how H. pylori causes disease. 
 In this thesis I describe how H. pylori can adapt to changes in its environment. 
While I investigate extracellular salt concentration as a model for a high salt diet, there 
are many other potential environmental factors (such as nutrient availability) that may 
affect H. pylori and its ability to cause disease. I mentioned MSG as a source of 
glutamate that may potentially alter the metabolic activity in H. pylori as an example. 
Other environmental factors including dietary metal intake or alternative carbon sources 
may also be factors that contribute to pathogenesis.  
 The gene encoding CagT is located on a pathogenicity island that is strongly 
correlated with severe disease outcomes. Gene products of this pathogenicity island are 
predicted to form a Cag T4SS that translocates CagA into host cells. However, currently 
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there is little functional data for most of the Cag T4SS components and very little is 
known about how the Cag T4SS translocates CagA into host cells. Understanding how 
this process occurs could potentially lead to development of new therapeutic 
approaches to combat H. pylori infection.  
 In summary, study of the bacterial cell-surface proteome is an important area of 
research that will enable us to better understand how H. pylori causes disease in its 
human host and how we may better treat infection in the future.  
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